Disorder of development or morphogenesis
MONDO:0021147Any disease or disorder that disrupts the process development of an anatomical structure. Can be due to genetic or environmental causes. Typically happens during embryogenesis, but also includes post-embryonic development.
4506 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 525 trials in this tab.
-
New MS drug trial for kids: could ocrelizumab help?
Disease control Not yet recruitingThis study tests a drug called ocrelizumab in children and teens aged 10 to 17 with relapsing-remitting multiple sclerosis (MS). The goal is to see how the drug moves through the body, if it is safe, and how it affects the immune system. Participants will receive the drug as a sh…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New study tracks Real-World safety of odevixibat in rare liver disease
Disease control Not yet recruitingThis study will follow 30 people with Alagille syndrome who are taking odevixibat in their daily lives. The goal is to see how safe the drug is over the long term by tracking any side effects. It is not testing if the drug works, but rather monitoring its real-world safety.
Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Alpelisib's Long-Term safety tracked in PIK3CA patients
Disease control Not yet recruitingThis study provides continued access to alpelisib for people who are already benefiting from it in a previous Novartis trial. It focuses on tracking long-term safety, including any side effects, in participants with PIK3CA-related overgrowth spectrum or certain breast cancers. Pa…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Double immune attack: new cell combo targets tough childhood cancers
Disease control Not yet recruitingThis early-phase study tests a new combination of two different immune cells—NK cells and CAR-T cells—for children and young adults with neuroblastoma or osteosarcoma that has returned or not responded to standard treatments. The NK cells are designed to help the CAR-T cells work…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New combo aims to fight merkel cell cancer when immunotherapy fails
Disease control Not yet recruitingThis study tests whether combining two drugs—ASTX727 (a pill) and retifanlimab (given through a vein)—can shrink tumors and control advanced Merkel cell cancer in people whose disease has worsened after standard immunotherapy. About 31 adults with stage III or IV Merkel cell canc…
Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Sugar supplement may calm seizures and stomach troubles in rare genetic disease
Disease control Not yet recruitingThis study tests whether a sugar called D-galactose (AVTX-801) can help people with SLC35A2-CDG, a rare inherited disorder that disrupts how the body adds sugar to proteins. The trial enrolls about 10 people of any age who have seizures or chronic digestive issues. Participants r…
Phase: PHASE2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can intense breathing training boost lung power and ease fatigue in MS?
Disease control Not yet recruitingThis study tests whether high-intensity breathing exercises can improve respiratory muscle strength, lung function, fatigue, and quality of life in people with multiple sclerosis (MS). Participants are randomly assigned to high-intensity interval breathing training, low-intensity…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Jaw vs. hip bone: which graft works best for cleft repair?
Disease control Not yet recruitingThis study compares two surgical techniques to repair a bone gap in the upper jaw (alveolar cleft) in 20 people who missed earlier treatment. One method uses bone from the patient's jaw, the other from the hip. Researchers will measure bone volume and shape after 6 months to see …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill may cut blood transfusions for kids with thalassemia
Disease control Not yet recruitingThis study tests a drug called mitapivat in children aged 1 to 17 with alpha- or beta-thalassemia who need regular blood transfusions. The goal is to see if mitapivat can reduce the number of transfusions needed compared to a placebo. The study involves 54 participants and lasts …
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New Pill-and-Immunotherapy combo aims to shrink melanoma before surgery
Disease control Not yet recruitingThis phase 2 trial tests whether adding an experimental immune-boosting pill (PRTX007) to standard immunotherapy (pembrolizumab) before surgery can improve outcomes for people with stage III melanoma. About 48 adults with resectable melanoma will take the combination for 9 weeks …
Phase: PHASE2 • Sponsor: Primmune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Denture cap showdown: which material saves more bone?
Disease control Not yet recruitingThis study will compare two materials used for the caps that attach dentures to dental implants: acetal resin and nylon. The goal is to see which one causes less bone loss around the implants and keeps gums healthier. Twenty-two people with no teeth in their lower jaw will be enr…
Phase: NA • Sponsor: Future University in Egypt • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New study: can a smart glucose monitor help diabetics with kidney problems?
Disease control Not yet recruitingThis study tests whether a real-time continuous glucose monitor (CGM) helps people with type 2 diabetes and chronic kidney disease keep their blood sugar in a healthy range. Thirty adults will either use the CGM or stick with standard fingerstick checks for three months. The goal…
Phase: NA • Sponsor: Hospital Universitario San Ignacio • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug hope for kids with MS: ublituximab trial launches
Disease control Not yet recruitingThis study tests the drug ublituximab in children aged 10 to 18 with relapsing multiple sclerosis (MS). It compares ublituximab to another drug, fingolimod, to see which better controls relapses. The trial involves 240 participants and will also monitor long-term safety and effec…
Phase: PHASE2, PHASE3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial
Disease control Not yet recruitingThis phase 1 trial tests a radioactive drug called 211At-MABG in 16 adults with advanced neuroendocrine cancers, including pheochromocytoma and paraganglioma. The drug delivers radiation directly to cancer cells that show up on a special scan. The main goal is to see if the treat…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI city halls: could Robot-Run domes cure addiction and homelessness?
Disease control Not yet recruitingThis study will test whether living in a self-contained, AI-managed community (called a Microcity) can improve mental health and reduce addiction in adults with conditions like autism, ADHD, substance use disorders, and behavioral addictions. Up to 1 million participants will liv…
Phase: NA • Sponsor: Veterans Recovery Network Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
First-in-Class cancer drug targets Hard-to-Treat tumors
Disease control Not yet recruitingThis study tests an experimental oral drug called VMD-102 in people with advanced solid tumors, including liver, lung, kidney, skin (uveal melanoma), and colorectal cancers that have not responded to standard treatments. The drug works by blocking a specific protein (PKC epsilon)…
Phase: PHASE1, PHASE2 • Sponsor: VM Discovery, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Gut-Focused drug revive immunotherapy for tough melanomas?
Disease control Not yet recruitingThis study tests whether adding axelopran, a drug that blocks opioid side effects in the gut, to the immunotherapy nivolumab can help people with advanced melanoma that no longer responds to PD-1 inhibitors. The trial includes about 28 adults with unresectable or metastatic cutan…
Phase: PHASE1, PHASE2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Glowing dye could help surgeons spot hidden epilepsy lesions
Disease control Not yet recruitingThis study tests whether a fluorescent dye called 5-ALA can help surgeons see and remove abnormal brain tissue in people with drug-resistant epilepsy caused by focal cortical dysplasia (FCD). FCD lesions are often hard to distinguish from healthy brain during surgery, making comp…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Scientists harness Patients' own immune cells to attack Treatment-Resistant melanoma
Disease control Not yet recruitingThis study tests a therapy called Perkileucel, made from a patient's own immune cells (tumor-infiltrating lymphocytes). These cells are collected from a surgically removed melanoma tumor, grown in a lab, and then infused back into the patient. Before the infusion, patients receiv…
Phase: PHASE2 • Sponsor: East Metropolitan Health Service, Australia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a stem cell shot before birth fix fanconi anemia?
Disease control Not yet recruitingThis early-phase trial tests whether giving healthy stem cells from the mother to a fetus diagnosed with Fanconi anemia can safely improve the baby's blood cell production. The treatment is a one-time injection into the fetus during pregnancy. The study will enroll 12 pregnant wo…
Phase: PHASE1, PHASE2 • Sponsor: Agnieszka Czechowicz • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Dialysis dilemma: catheter or fistula for the elderly?
Disease control Not yet recruitingThis study compares two common ways to access the blood for dialysis: a tunneled catheter (a tube placed in a large vein) versus a surgically created fistula (connecting an artery to a vein). The trial will enroll 220 patients aged 60 or older (or younger but with multiple health…
Phase: NA • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with sanfilippo syndrome b?
Disease control Not yet recruitingThis early-stage trial tests a new drug called JR-446 in 12 children under 6 with MPS IIIB, a rare genetic disorder that damages the brain and body. The main goal is to see if the drug is safe and tolerable. Researchers will also measure changes in certain substances in the body …
Phase: PHASE1, PHASE2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smarter magnesium testing could shield Children's hearts and kidneys after surgery
Disease control Not yet recruitingThis study tests two ways of measuring magnesium in the blood to personalize magnesium sulfate (MgSO4) dosing for children after heart surgery. Low magnesium levels can lead to heart rhythm problems and kidney injury. One method measures total magnesium, while the other measures …
Phase: NA • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI-Powered tool aims to sharpen MS treatment choices
Disease control Not yet recruitingThis study tests a computer program called PRIMUS that helps neurologists choose treatments for people with relapsing-remitting multiple sclerosis (MS). The tool uses data from past patients to predict how the disease might progress under different therapies. Doctors in some clin…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study could change how Men's UTIs are treated
Disease control Not yet recruitingThis study tests whether a common antibiotic for women's UTIs, fosfomycin-trometamol, works well for men with urinary tract infections. Current treatments can have serious side effects and increase antibiotic resistance. The trial will enroll 138 men in primary care and monitor f…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Smart insulin pump could transform hospital diabetes care
Disease control Not yet recruitingThis trial compares an automated insulin delivery system (AID) to standard insulin injections for managing blood sugar in hospitalized adults with type 2 diabetes who have an infection. The AID system uses a continuous glucose monitor and a smart pump to automatically adjust insu…
Phase: NA • Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Gentle exercise with cuffs may boost muscle in MS patients
Disease control Not yet recruitingThis study tests whether adding blood flow restriction cuffs to light leg exercises can help people with relapsing-remitting multiple sclerosis build bigger, stronger thigh muscles. Thirty participants will do the same exercise twice a week for 8 weeks, but some will have the cuf…
Phase: NA • Sponsor: Hanifi Bal • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple nutrient shake help preemies breathe easier?
Disease control Not yet recruitingThis study tests whether adding DHA/ARA supplements to the milk of extremely premature babies (born at 28 weeks or earlier) during their first two weeks of life can reduce the severity of bronchopulmonary dysplasia, a chronic lung disease. About 150 babies will be randomly assign…
Phase: PHASE1, PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for teens with rare nerve disease: drug trial launches
Disease control Not yet recruitingThis study tests a new medicine called empasiprubart in teenagers aged 12 to 17 who have a rare nerve disease called CIDP. The goal is to find the right dose and see if the drug is safe and helps control the disease. Participants will receive the drug for about 27 months and be f…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could cord blood transfusions protect fragile preemies?
Disease control Not yet recruitingThis study tests whether using cord blood, rich in fetal hemoglobin, for transfusions in preterm infants can reduce serious complications like blindness, lung disease, and gut problems. Researchers will compare outcomes in 200 very low birth weight babies who receive either cord …
Phase: NA • Sponsor: University of Parma • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Bladder cocktail aims to stop recurrent UTIs in spinal cord injury
Disease control Not yet recruitingThis early study tests whether washing the bladder with an antibiotic (gentamicin) followed by a probiotic (Lactobacillus) can help restore healthy bacteria and prevent urinary tract infections in people with neurogenic bladder due to spinal cord injury, multiple sclerosis, or sp…
Phase: EARLY_PHASE1 • Sponsor: Medstar Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy takes on advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called N-3C01, given alone or with an immunotherapy, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the right dose, and see if the combination shrinks tumors. About 114 a…
Phase: PHASE1, PHASE2 • Sponsor: Hefei Xinzhu Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a COVID shot help fight lung cancer? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether giving a Pfizer-BioNTech COVID-19 mRNA vaccine before standard immunotherapy (pembrolizumab) and chemotherapy can improve outcomes for people with stage 4 non-small cell lung cancer. Researchers will enroll 500 adults to see if the vaccine helps the immun…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Herbal granules aim to slow early puberty in young girls
Disease control Not yet recruitingThis study tests whether Sanghe Jianghuo Granules, a traditional Chinese herbal medicine, can safely slow down early puberty in girls aged 5 to 8.5 years. The trial will involve 200 participants who will take the granules or a placebo twice daily for 3 months. The main goal is to…
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common diabetes drug boost immunotherapy in Hard-to-Treat cancers?
Disease control Not yet recruitingThis early-phase trial is testing whether adding sitagliptin, a diabetes drug, to the immunotherapy pembrolizumab is safe and can help people with advanced kidney cancer or melanoma whose cancer has stopped responding to standard treatment. The study will first find the safest do…
Phase: PHASE1 • Sponsor: Fernando Maciel Barbosa • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Brain training boosts shoulder rehab? new trial investigates
Disease control Not yet recruitingThis study tests whether adding brain-challenging exercises (like reacting to lights while moving) to standard physical therapy helps people recover better after shoulder stabilization surgery. Thirty-two adults who had surgery for shoulder instability will be randomly assigned t…
Phase: NA • Sponsor: Hacettepe University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug aims to stop nosebleeds in rare blood vessel disorder
Disease control Not yet recruitingThis study tests an experimental drug called ATV-1601 in people with moderate to severe HHT, a condition that causes frequent nosebleeds and anemia. The trial has two parts: first, participants receive either the drug or a placebo to check safety and effectiveness; then, all elig…
Phase: PHASE1, PHASE2 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New tool may prevent artery blockage during heart valve replacement
Disease control Not yet recruitingThis study looks at a device called ShortCut that splits old heart valve leaflets before placing a new valve inside it. The goal is to keep the arteries open and prevent blockages. About 150 people with aortic stenosis who are at risk for this complication will take part. Researc…
Sponsor: Pi-cardia • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for kids with resistant cancers: targeted drug enters trial
Disease control Not yet recruitingThis study tests a drug called ifinatamab deruxtecan (I-DXd) in children with solid tumors that have returned or not responded to treatment. The drug is an antibody-drug conjugate that targets cancer cells directly. The trial aims to check safety and see if tumors shrink in about…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New dissolving stent could spare kids repeated heart surgeries
Disease control Not yet recruitingThis trial tests a new type of stent that dissolves over time for children under 9 with narrowed arteries in or near the heart. The stent opens the vessel and then gradually disappears, allowing the artery to grow naturally. The study will enroll 45 children and follow them for 5…
Phase: NA • Sponsor: PediaStent LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a cancer drug boost social abilities in rare genetic condition?
Disease control Not yet recruitingThis study tests whether everolimus, a drug already approved for other conditions, can safely improve social abilities in people with PTEN Hamartoma Tumor Syndrome (PHTS). About 60 adults and children with PHTS and social difficulties will take either everolimus or a placebo for …
Phase: PHASE2, PHASE3 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
MS patients switch drugs to save immune defenses
Disease control Not yet recruitingThis study follows 115 adults with multiple sclerosis who are switching from ocrelizumab to ofatumumab because their antibody levels dropped. Researchers want to see if the switch stops or slows that decline over 24 months. The goal is to better manage immune health while still t…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare mitochondrial diseases that cause severe symptoms like strokes and vision loss. The trial is open-label (everyone gets the drug) and uses each person as their own control over…
Phase: PHASE1, PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to shrink melanoma before surgery
Disease control Not yet recruitingThis study tests whether giving two immunotherapy drugs (fianlimab and cemiplimab) before surgery can shrink melanoma tumors in people with stage IIIB to IV melanoma. About 35 adults will receive the drugs, then have surgery to remove any remaining cancer. The main goal is to see…
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for immunotherapy side effects: blood filtering may replace steroids
Disease control Not yet recruitingThis study tests a treatment called extracorporeal photopheresis (ECP) for people with advanced melanoma who develop severe colitis or hepatitis from immunotherapy. ECP filters a patient's blood, treats it with a light-activated drug, and returns it to the body. The trial compare…
Phase: PHASE2 • Sponsor: Therakos LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New study aims to simplify care for patients with multiple leaky heart valves
Disease control Not yet recruitingThis study tests a step-by-step treatment plan for people with a narrowed aortic valve who also have leaky mitral or tricuspid valves. After a minimally invasive procedure to fix the aortic valve, doctors will check if the other valves still leak badly. If so, additional procedur…
Sponsor: Josep Rodes-Cabau • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can TAVI be done safely without a surgery team on standby?
Disease control Not yet recruitingThis study looks at whether a common heart valve procedure called TAVI is safe when done in hospitals that don't have heart surgery available on-site. About 600 people with severe aortic stenosis will be randomly assigned to have TAVI either with or without surgical backup. The g…
Phase: PHASE4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could extended CPAP save preterm Babies' lungs?
Disease control Not yet recruitingThis study tests whether keeping very preterm babies on CPAP (a breathing machine) until 34 weeks after conception, instead of switching to a nasal cannula, reduces their risk of bronchopulmonary dysplasia (a chronic lung disease) or death. About 860 infants born before 29 weeks …
Phase: NA • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New weekly shot could help girls with turner syndrome grow taller
Disease control Not yet recruitingThis phase 3 study tests a new weekly growth hormone injection (inpegsomatropin) against an existing one (givopegsomatropin) in 84 girls with Turner syndrome who have short stature. The goal is to see which works better for increasing growth over 52 weeks. Participants are prepub…
Phase: PHASE3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat cancers: drug targets MTAP deletion
Disease control Not yet recruitingThis phase 2 trial tests a drug called BMS-986504 in people with advanced solid tumors that have lost a gene called MTAP. The drug is given alone or with other cancer medicines. The study aims to see if the drug shrinks tumors and how safe it is. About 260 adults will take part.
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New MS biosimilar PB018 faces first human test against ocrevus
Disease control Not yet recruitingThis Phase 1 trial will test PB018, a biosimilar to the MS drug Ocrevus, in 222 people with multiple sclerosis. The study compares how the body processes PB018 versus Ocrevus and checks for safety. Participants will receive either PB018 or Ocrevus, but neither they nor their doct…
Phase: PHASE1 • Sponsor: Polpharma Biologics International AG • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New eye lens could let cataract patients ditch glasses
Disease control Not yet recruitingThis study tests a new type of artificial lens for cataract surgery that may adjust focus like a natural lens. About 100 adults needing cataract surgery will get this lens in one eye and a standard lens in the other. Researchers will check for complications and measure vision imp…
Phase: NA • Sponsor: Adaptilens, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New scoring tool aims to reverse type 2 diabetes with personalized plans
Disease control Not yet recruitingThis study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each patient. 150 adults will follow a personalized 24-week lifestyle and nutrition plan based on their SMS results. The goal…
Phase: NA • Sponsor: Salah Snouda • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
MS patients may soon get a simpler shot option
Disease control Not yet recruitingThis study looks at whether people with multiple sclerosis can safely switch from their current anti-CD20 therapy to a new under-the-skin version of ocrelizumab. About 100 participants will be followed for up to 48 weeks to see if brain lesions stay stable and if they are satisfi…
Phase: PHASE4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Treadmill training may boost walking skills in kids with heart defects
Disease control Not yet recruitingThis study looks at whether moderate treadmill walking can improve how children aged 4 to 6 with surgically corrected acyanotic congenital heart disease walk, balance, and move. Eighty children will take part, with some doing treadmill sessions four times a week for 10 weeks. Res…
Phase: NA • Sponsor: Delta University for Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a simple cream reduce the need for major mole removal surgery?
Disease control Not yet recruitingThis early-phase trial tests whether a topical cream called squaric acid dibutyl ester (SADBE) can safely reduce pigment-producing cells in large congenital moles before they are surgically removed. Thirty adults with these birthmarks will apply the cream or a placebo for several…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Freeze then ointment: new combo tackles precancerous skin spots
Disease control Not yet recruitingThis study tests whether freezing precancerous skin spots (cryotherapy) followed by a medicated ointment (tirbanibulin) works better than freezing alone for actinic keratosis on the scalp and forehead. About 59 adults with at least 8 spots will receive the combo treatment or a pl…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New injection shows promise for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of lymphoma that has come back or not responded to treatment. The main goal is to find a safe dose and check for side effects. About 14 participants will receive the drug as a sh…
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New Bone-Strengthening device for osteoporosis under review
Disease control Not yet recruitingThis study will review medical records and call patients who received AGN1 LOEP, a device injected into the hip bone to treat osteoporosis. Researchers want to see how many patients later had hip fractures and whether any side effects occurred. The goal is to understand how well …
Sponsor: AgNovos Healthcare, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for Hard-to-Treat breast cancer: drug combo targets resistant tumors
Disease control Not yet recruitingThis study tests a new drug, prifetrastat, combined with fulvestrant for people with advanced HR+/HER2- breast cancer that has stopped responding to standard hormone therapy and CDK4/6 inhibitors. About 51 participants will receive the combination to see if it can shrink tumors o…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can group exercise help fragile bones? new study aims to find out
Disease control Not yet recruitingThis study will test whether a 12-week group exercise program is safe and practical for people with osteoporosis who have recently had a fracture. One hundred participants will attend twice-weekly classes and undergo bone scans and interviews. The goal is to see if this type of p…
Phase: NA • Sponsor: Western University, Canada • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New MS drug trial uses Super-Powered MRI to see inside the brain
Disease control Not yet recruitingThis study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years and undergo powerful 7T MRI scans to measure changes in brain volume, lesions, and tissue health. The g…
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New lens aims to sharpen vision after cataract surgery
Disease control Not yet recruitingThis study tests a new trifocal intraocular lens (IOL) for people having cataract surgery. The lens is designed to help see clearly at near, intermediate, and far distances. Researchers will compare the new lens to a commercially available one in 66 participants, measuring distan…
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heart drugs may boost recovery after valve surgery
Disease control Not yet recruitingThis study tests whether two heart failure medications, dapagliflozin and spironolactone, can help the heart recover better after aortic valve replacement. About 445 adults with severe aortic stenosis will take one or both drugs daily for 12 months. The goal is to see if these me…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug MTM-H-001 targets B-Cell autoimmune diseases in early trial
Disease control Not yet recruitingThis early study tests a new drug called MTM-H-001 in 75 adults with B-cell-related autoimmune diseases, including lupus, multiple sclerosis, and rheumatoid arthritis. The main goal is to check safety and find the right dose. Participants receive the drug by injection, and resear…
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Lifestyle makeover tested as MS symptom fighter
Disease control Not yet recruitingThis study tests whether a structured 12-week program focusing on nutrition, exercise, sleep, and stress management can improve fatigue, physical function, and quality of life in people with relapsing-remitting multiple sclerosis. Thirty participants will first be observed for 12…
Phase: NA • Sponsor: New York University Abu Dhabi • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a bone drug prevent spine surgery failures?
Disease control Not yet recruitingThis study looks at whether a drug called abaloparatide can improve bone quality in people with osteoporosis who need spine surgery. About 60 participants will take the drug for 3-6 months before and after surgery. The goal is to see if it reduces complications like broken hardwa…
Phase: PHASE2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New keytruda copycat tested in melanoma patients after surgery
Disease control Not yet recruitingThis study tests a new drug called Bmab1800 to see if it works like the approved drug Keytruda in people with stage IIB, IIC, or III melanoma after their tumor has been removed by surgery. About 138 adults will get either Bmab1800 or Keytruda, and researchers will compare how the…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New gene therapy trial targets tough autoimmune conditions
Disease control Not yet recruitingThis early-stage study tests a new treatment called LVIVO-TaVec400 in 44 people with severe autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis that have not responded to standard therapies. The main goals are to check the treatment's safety and find the rig…
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New CAR-T therapy targets tough MS cases in early safety trial
Disease control Not yet recruitingThis early study tests a new treatment called S103 (BCMA-CAR T cells) in 9 adults with progressive or hard-to-treat multiple sclerosis (MS). The main goal is to see if the treatment is safe and to find the best dose. Researchers will also look for early signs that it might help c…
Phase: PHASE1 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New mRNA shot targets Hard-to-Treat cancers in early human test
Disease control Not yet recruitingThis early-phase study tests a new mRNA medicine (NCP-IL-22BP mRNA) in 9 people with advanced solid tumors that have not responded to standard treatments. The medicine is injected directly into tumors to help the body fight cancer. The main goal is to check safety and find the ri…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Less invasive heart valve replacement put to the test against Open-Heart surgery
Disease control Not yet recruitingThis study compares two standard procedures—minimally invasive TAVR and open-heart surgery (SAVR)—for replacing a diseased aortic valve in people with a bicuspid aortic valve. About 1,200 participants aged 50 and older with severe aortic stenosis will be randomly assigned to one …
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hope for sanfilippo kids: Brain-Infused drug enters final testing
Disease control Not yet recruitingThis phase 3 trial tests a drug called tralesinidase alfa in 14 children aged 1-5 with Sanfilippo syndrome type B, a rare genetic disease that causes severe brain damage. The drug is given directly into the brain fluid to replace a missing enzyme. The goal is to see if it can slo…
Phase: PHASE3 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could the time of day you get immunotherapy boost its power against melanoma?
Disease control Not yet recruitingThis study looks at whether giving immunotherapy infusions in the morning improves outcomes for people with advanced melanoma. Researchers will compare morning versus afternoon/evening dosing in 108 participants. The goal is to see if aligning treatment with the body's natural im…
Phase: PHASE4 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could donor stem cells help kids with brittle bones grow taller and stronger?
Disease control Not yet recruitingThis early-phase trial tests whether infusions of donor bone marrow stem cells (MSCs) are safe and can improve growth and bone health in 12 children aged 3–10 with severe osteogenesis imperfecta type 3. The study will monitor side effects, growth rates, fracture healing, and bone…
Phase: PHASE1, PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for heart patients: drug may cut death risk after valve surgery
Disease control Not yet recruitingThis study tests whether the drug finerenone can help people with heart failure who have had a heart valve replacement (TAVI). About 2,800 older adults will be randomly assigned to receive finerenone or a placebo. The goal is to see if the drug lowers the chance of death or worse…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New study targets tough heart valve cases with advanced device
Disease control Not yet recruitingThis study looks at how safe and effective the SAPIEN 3 heart valve is for people with a certain type of bicuspid aortic valve stenosis (Type-0). About 170 people in China will be observed after the procedure to track serious problems like death, stroke, or rehospitalization. The…
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Cancer-Killing virus trial launches for melanoma that spread to brain
Disease control Not yet recruitingThis early-phase trial tests a virus called DNX-2401, designed to infect and destroy melanoma cells in the brain and body. About 50 adults with stage IV melanoma will receive injections to find the safest dose and number of treatments. The main goal is to check for side effects, …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Not yet recruitingThis study tests a daily injection called elamipretide in 48 people with genetically confirmed Barth syndrome, a rare condition that causes muscle weakness and heart problems. Participants will receive either the drug or a placebo for 72 weeks. The main goal is to see if the drug…
Phase: PHASE4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New heart valve implant could offer hope for moderate aortic stenosis patients
Disease control Not yet recruitingThis study compares a new heart valve implant (Myval) to standard medication in 778 people aged 65+ with moderate aortic stenosis. The goal is to see if the implant reduces death, stroke, heart failure, and improves quality of life over 2 years. Participants will be randomly assi…
Phase: NA • Sponsor: Meril Life Sciences Pvt. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New heart valve registry aims to confirm Real-World success
Disease control Not yet recruitingThis study will track 100 people with severe aortic stenosis who receive the Hydra THV heart valve through a less invasive procedure (TAVR). The goal is to see how well the valve works and how safe it is in everyday practice. Participants will be followed for short- and mid-term …
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New Immune-Calming therapy could slow progressive MS
Disease control Not yet recruitingThis phase IIa trial tests a personalized cell therapy for people with progressive multiple sclerosis (MS). The treatment uses the patient's own immune cells, turned into 'tolerogenic dendritic cells' that are designed to calm the immune system and stop it from attacking the nerv…
Phase: PHASE2 • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New procedure aims to stop Liver-Related confusion by blocking rogue blood vessels
Disease control Not yet recruitingThis study tests a new procedure that uses an endoscope (a thin tube with a camera) to guide coils and glue into abnormal blood vessels in the liver. The goal is to block these vessels and reduce severe confusion (hepatic encephalopathy) in people with liver cirrhosis. The trial …
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can extra calories help kids with heart disease grow stronger?
Disease control Not yet recruitingThis study tests whether high-calorie diets and special nutritional formulas can help underweight children aged 1 to 5 with congenital heart disease gain weight. Seventy-five children will be split into three groups: standard diet, high-calorie diet, or high-calorie diet plus a s…
Phase: NA • Sponsor: Aryan Najmadin Nasradin • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Italian study examines targeted radiation for rare gland tumors
Disease control Not yet recruitingThis study looks back at how well a type of targeted radiation therapy (PRRT) works for people with advanced pheochromocytoma and paraganglioma, rare tumors of the adrenal glands. Researchers will analyze data from about 210 patients treated in Italy over 24 years. The goal is to…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gold nanorods heat up tumors in new melanoma trial
Disease control Not yet recruitingThis early study tests a new treatment for advanced skin melanoma that has not responded to standard therapies. Ten participants will receive two injections of gold nanorods directly into their tumors, which are then activated with a special light to generate heat and destroy can…
Phase: NA • Sponsor: Sona Nanotech Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental cell therapy takes on multiple sclerosis
Disease control Not yet recruitingThis early-stage trial tests a new treatment for multiple sclerosis (MS) that combines a drug called ofatumumab with NK042, a therapy made from immune cells donated by healthy people. The study will include 20 adults with different types of MS and will primarily check for safety …
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Head-to-Head: which new heart valve is best for aortic stenosis?
Disease control Not yet recruitingThis trial compares two latest-generation heart valves (SAPIEN 3 Ultra Resilia and Evolut FX) in 200 patients with severe aortic stenosis. Participants will be randomly assigned to receive one valve during a standard procedure and followed for one year. The goal is to see which v…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could ultrasound replace X-Rays in heart valve surgery?
Disease control Not yet recruitingThis study tests whether using only ultrasound (echocardiography) to guide a minimally invasive heart valve replacement is as effective as the standard method that combines X-ray and ultrasound. The goal is to reduce kidney injury from contrast dye and lower radiation exposure. A…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a Once-Daily probiotic help bones? new trial begins
Disease control Not yet recruitingThis study tests whether a new once-daily version of a probiotic food (SBD111) works as well as the current twice-daily version in healthy adults aged 35 and older. The goal is to see if the new formula leads to similar levels of helpful gut microbes. Participants take capsules f…
Phase: NA • Sponsor: Solarea Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Custom 3D-Printed bone implants: a new hope for defect repair?
Disease control Not yet recruitingThis trial is testing whether custom-made 3D-printed titanium implants are safe and work well for people with bone defects. Ten patients will receive an implant designed from their own CT or MRI scans. The study will track complications, implant stability, and bone healing over t…
Phase: NA • Sponsor: VinUniversity • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Nano-ink gel could replace repeated skull surgeries for kids with rare genetic disorders
Disease control Not yet recruitingThis early-stage study aims to develop a personalized treatment for children with syndromic craniosynostosis, a group of rare genetic disorders where skull bones fuse too early. The approach uses a nano-engineered gel to deliver custom genetic medicine directly to the affected ar…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a diabetes drug strengthen bone repair in kids with cleft palate?
Disease control Not yet recruitingThis study tests whether adding metformin gel to a standard bone graft improves bone quality in children aged 8 to 12 with a cleft in the upper jaw (alveolar cleft). 36 participants will be randomly assigned to receive either the metformin-enhanced graft or a placebo. The main go…
Phase: PHASE2 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for kids with tough cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests whether adding the drug naxitamab to standard chemotherapy is safe and effective for children and young adults newly diagnosed with high-risk neuroblastoma, an aggressive nerve cell cancer. Ten participants aged 1 to 21 will receive the combination and be monitor…
Phase: PHASE2 • Sponsor: Shaare Zedek Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New triple combo aims to tackle Hard-to-Treat liver cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few other spots and no longer responds to first-line treatment. The goal is to see if this triple therapy can slow …
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New biosimilar aims to match cancer drug OPDIVO at lower cost
Disease control Not yet recruitingThis Phase 1 trial tests whether HLX18, a biosimilar of the cancer drug OPDIVO, works similarly in people with esophageal, melanoma, or bladder cancer after their tumors have been surgically removed. About 174 participants will receive either HLX18 or OPDIVO to compare how the dr…
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New device offers hope for heart defect patients with failing circulation
Disease control Not yet recruitingThis study looks at a device called the Occlutech Atrial Flow Regulator (AFR) in 25 people whose Fontan circulation (a surgery for a heart defect) is failing. The goal is to see if the device is safe and works well to create a small hole between heart chambers to improve blood fl…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Sound waves instead of surgery: new device aims to soften stiff heart valves
Disease control Not yet recruitingThis registry will follow 200 people with severe aortic valve stenosis who receive a non-invasive ultrasound therapy called Valvosoft. The treatment uses focused sound waves to soften calcium buildup on the valve without surgery. Researchers will track safety and effectiveness fo…
Sponsor: Cardiawave SA • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Dissolvable heart patch could spare patients from surgery
Disease control Not yet recruitingThis trial tests a new device called Absnow II that closes a common heart hole (atrial septal defect) and then dissolves over time. About 236 people with a hole between 5 and 26 mm will get either the new device or a standard one. The goal is to see if the new device works just a…
Phase: NA • Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Robot-Assisted surgery for kids: a safer option?
Disease control Not yet recruitingThis study tests a new robotic system designed to help surgeons perform chest and belly surgeries in children. It will include 64 kids under 18 who need common surgeries like kidney repair or lung removal. The goal is to see if the robot is safe and works as well as standard surg…
Phase: NA • Sponsor: Hangzhou Kangji Weijing Medical Robotics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for kids with tough neuroblastoma: drug combo trial opens
Disease control Not yet recruitingThis study tests adding a new drug, iberdomide, to standard chemoimmunotherapy for children and young adults (ages 1-30) whose neuroblastoma has returned, not responded, or worsened after prior treatment. The goal is to see if the combination is safe and works better at controlli…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Gene therapy hope for rare childhood disease AGU
Disease control Not yet recruitingThis early-stage trial tests a single dose of a gene therapy called DANAGALEX in 9 adults and children with aspartylglucosaminuria (AGU), a rare genetic disorder. The goal is to see if the treatment is safe and can reduce harmful substances in the body. Researchers will monitor s…
Phase: PHASE1, PHASE2 • Sponsor: Rare Trait Hope • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
AI assistant aims to keep heart surgery patients out of the hospital
Disease control Not yet recruitingThis study tests whether a smartphone app powered by artificial intelligence can help adults recover after heart surgery. 500 patients will either use the app plus standard care or standard care alone. The app gives personalized advice on medications, spotting complications early…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo aims to tackle tough brain tumors in NF1 patients
Disease control Not yet recruitingThis phase 2 trial tests the drug mirdametinib, alone or with radiation, in people with NF1-related high-grade gliomas (aggressive brain tumors). It includes three groups: those with recurrent sporadic glioblastoma, newly diagnosed NF1-associated glioblastoma, and other NF1-relat…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New heart valve trial aims to improve Second-Time valve replacements
Disease control Not yet recruitingThis trial is for people whose surgically implanted aortic heart valve has stopped working properly. It compares two types of replacement valves placed through a tube in the leg (TAVI): a newer self-expanding valve (Hydra) versus standard balloon-expandable valves (Sapien or MyVa…
Phase: NA • Sponsor: National University of Ireland, Galway, Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental STAR-T cell therapy aims to tame multiple sclerosis
Disease control Not yet recruitingThis early-stage trial will test the safety of a new immune cell therapy called universal STAR-T cells in 24 adults with multiple sclerosis (MS) who have no other treatment options. The therapy involves infusing specially engineered cells that may help control the disease. The st…
Phase: PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New cell therapy aims to supercharge Kids' immune cells after transplant
Disease control Not yet recruitingThis early-phase trial tests a new cell therapy called ThINKK in 12 children aged 2–12 who have had a stem cell transplant for leukemia or neuroblastoma. The therapy is designed to boost the body's natural killer (NK) cells to better fight cancer. The main goals are to check if t…
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy aims to hit MS early and hard
Disease control Not yet recruitingThis study tests whether giving two strong medications one after the other—rituximab then cladribine—is safe and works well for people with relapsing-remitting multiple sclerosis (MS). Sixty adults aged 18 to 50 with active MS within the last year will receive the treatment and b…
Phase: PHASE2 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug duo aims to fight rare melanoma before surgery
Disease control Not yet recruitingThis phase II trial tests two drugs—SHR-1701 (an immunotherapy) and famitinib (which cuts off tumor blood supply)—given before surgery for resectable mucosal melanoma, a rare and aggressive skin cancer. After surgery, treatment is tailored based on how well the tumor responded. T…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Engineered immune cells take on deadly childhood brain cancer
Disease control Not yet recruitingThis early-stage trial tests a new treatment for children with a rare, aggressive brain tumor called ATRT that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack the tumor, plus a…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Triple drug attack on melanoma: new trial hopes to boost surgery success
Disease control Not yet recruitingThis phase 2 trial tests three immune-boosting drugs (cemiplimab, fianlimab, and ipilimumab) given before surgery in 20 people with advanced but removable melanoma. The goal is to see if the combination is safe and can shrink tumors, potentially improving outcomes. Participants m…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill aims to ease fatigue in rare mitochondrial disease
Disease control Not yet recruitingThis study is for people who completed a previous trial of KL1333 (napazimone) for primary mitochondrial disease. It will test the drug's long-term safety and whether it helps with fatigue and daily activities. About 140 participants will take the pill twice daily for an extended…
Phase: PHASE2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Heart valve fix without a surgeon in the building? new trial aims to prove It's safe
Disease control Not yet recruitingThis study looks at whether a common heart valve replacement (TAVI) can be performed safely in hospitals that do not have a cardiac surgery team on-site. Currently, TAVI is only done in hospitals with heart surgery backup, which can cause long wait times. The trial will randomly …
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a cholesterol drug stop a heart valve from hardening?
Disease control Not yet recruitingThis study tests whether a drug called a PCSK9 inhibitor (Tafolecimab) can slow the progression of mild to moderate calcific aortic stenosis, a condition where the heart valve narrows and hardens. Researchers will give the drug to half of 160 participants and compare changes in v…
Phase: PHASE3 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Which surgery fixes clubfoot best? new trial aims to find out
Disease control Not yet recruitingThis trial compares two surgical procedures for children aged 5 to 10 with relapsed clubfoot and a specific foot deformity called metatarsal adductus. One surgery involves cutting and realigning the midfoot bones, followed by 6 weeks in a cast. The other uses a small plate to gui…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New biosimilar aims to match opdivo for melanoma
Disease control Not yet recruitingThis study tests whether a new drug called Bmab1700 works the same as the approved immunotherapy Opdivo in people with melanoma who have had their tumors surgically removed. The trial will involve 120 adults with stage IIB to IV melanoma. Researchers will compare how the drugs mo…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Single-Patient trial aims to tackle obesity in rare bone disorder
Disease control Not yet recruitingThis phase 2 trial tests the drug setmelanotide in one person with pseudohypoparathyroidism type 1a (PHP1a), a rare genetic disorder that often causes severe obesity. The participant will receive daily injections of setmelanotide for six months to see if it leads to weight loss a…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo aims to keep prostate cancer in check with lower chemo dose
Disease control Not yet recruitingThis study tests a combination of darolutamide, hormone therapy, and a lower dose of the chemotherapy drug docetaxel in men with metastatic hormone-sensitive prostate cancer. The goal is to see if this approach can keep PSA levels very low (below 0.2 ng/mL) at 24 weeks while redu…
Phase: PHASE2 • Sponsor: Yonghong Li • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New heart valve under 10-Year watch: will it last?
Disease control Not yet recruitingThis registry will follow 500 adults with severe aortic stenosis who receive a SAPIEN 3 Ultra Resilia heart valve through a minimally invasive procedure. Researchers will track how well the valve works and how safe it is over 10 years. The goal is to see if this newer valve desig…
Sponsor: Institut für Pharmakologie und Präventive Medizin • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
MS drug delivery showdown: belly vs. thigh, pen vs. syringe
Disease control Not yet recruitingThis study tests a drug called ublituximab, given as a shot under the skin, in 350 people with relapsing multiple sclerosis. Researchers want to see how the drug moves through the body when injected in different spots (like the belly or thigh) and whether an autoinjector pen work…
Phase: PHASE2 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Cord blood transfusions could be safer for preterm babies
Disease control Not yet recruitingThis study compares transfusions using red blood cells from umbilical cord blood versus standard adult donor blood in extremely premature infants. About 176 babies born before 28 weeks or weighing under 1000 grams will be enrolled. The goal is to see if cord blood reduces the ris…
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a common numbing drug shield Babies' lungs after heart surgery?
Disease control Not yet recruitingThis study tests whether giving the numbing drug lidocaine during heart surgery can reduce lung damage in infants. 320 babies under 1 year old having heart surgery will receive either lidocaine or a placebo. The goal is to see if lidocaine lowers the severity of lung injury after…
Phase: PHASE4 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New Triple-Drug attack before surgery shows promise for tough skin cancer
Disease control Not yet recruitingThis study tests whether giving three drugs (pucotenlimab, lenvatinib, and temozolomide) before surgery can shrink tumors in people with a specific type of skin cancer called acral melanoma, which is stage IIB or III and can be removed. About 30 adults will receive the drug combi…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug aims to tame rare artery disease
Disease control Not yet recruitingThis phase 2 trial tests whether secukinumab, a drug that blocks IL-17A, can help people with active severe Takayasu arteritis achieve remission and stop taking steroids. About 52 participants will receive either secukinumab injections or standard care (like TNF inhibitors). The …
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug hopes to ease rare Heart-Lung condition
Disease control Not yet recruitingThis study tests a drug called sotatercept in 40 adults with congenital heart disease and Eisenmenger syndrome, a serious condition where blood flow in the lungs is blocked. The drug is given as a shot every three weeks for 24 weeks. The goal is to see if it safely lowers pressur…
Phase: PHASE2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Surgery or no surgery? new study tackles borderline hip dysplasia dilemma
Disease control Not yet recruitingThis study compares two treatments for borderline hip dysplasia: arthroscopic surgery or a 3-month non-surgical plan with education, pain relievers, supplements, and exercise. About 248 adults aged 18-42 will be randomly assigned to one of the two groups. Researchers will track p…
Phase: NA • Sponsor: ChunBao Li • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New device aims to seal heart hole and prevent second strokes
Disease control Not yet recruitingThis study compares two medical devices used to close a small hole in the heart called a PFO, which can cause strokes. About 1,260 adults who have had a stroke or mini-stroke in the past year will be randomly assigned to receive either the Cocoon PFO Occluder or the Amplatzer PFO…
Phase: NA • Sponsor: Giuseppe Tarantini • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Gentle second chance: new Valve-in-Valve study for failing heart valves
Disease control Not yet recruitingThis study follows about 300 patients across Europe who need a second minimally invasive heart valve replacement (TAVI-in-TAVI) because their first valve has worn out or is leaking. Doctors will use the Myval valve for the replacement. The study will track how well the procedure …
Sponsor: IHF GmbH - Institut für Herzinfarktforschung • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New invisalign expander vs traditional device: which works better for Kids' jaw problems?
Disease control Not yet recruitingThis study compares the Invisalign Palatal Expander (IPE) with the Rapid Palatal Expander (RPE) in children aged 8–12 who have a narrow upper jaw and an underbite (skeletal Class III). Participants will wear a facemask after expansion. Researchers use 3D X-rays to measure changes…
Phase: NA • Sponsor: Mahidol University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study blends ancient herbs with modern medicine to slow early puberty
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese medicine herbal formula (Sanghe Jianghuo Granules) to standard Western treatment can better manage precocious puberty in girls aged 5 to 9. The goal is to slow down early breast development and bone aging, and improve final he…
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental cell therapy takes on Drug-Resistant melanoma
Disease control Not yet recruitingThis Phase 2 trial tests a new cell therapy called RAPA-201 for people with advanced melanoma that has stopped responding to PD-(L)1 inhibitors. The therapy uses a patient's own immune cells, modified to resist the drug rapamycin, and is given along with chemotherapy. The study a…
Phase: PHASE2 • Sponsor: Rapa Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for rare blood vessel disorders: everolimus trial launches
Disease control Not yet recruitingThis phase 2 trial tests the drug everolimus in 67 people with vascular anomalies (abnormal blood vessels) that haven't responded to standard treatments. The goal is to shrink the lesions and improve symptoms. Participants take everolimus daily for 6 months, with doses adjusted b…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a simple heart pump save lives after a heart attack complication?
Disease control Not yet recruitingThis study tests whether inserting a heart pump (IABP) early, before severe shock develops, can reduce deaths in patients who develop a hole in the heart after a heart attack. The trial will enroll 100 patients across 5 centers, randomly assigning half to receive the pump within …
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a diabetes pill boost heart health in fontan patients?
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug already approved for diabetes and heart failure, can improve exercise ability and heart function in people who have had the Fontan procedure. About 30 participants aged 12 and older will take the drug daily for 3 months. The goal is …
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for kids with MS: safer drug combo aims to stop relapses
Disease control Not yet recruitingThis study tests two drugs, diroximel fumarate and dimethyl fumarate, in children with relapsing multiple sclerosis. About 185 kids will be split by weight and randomly assigned to one of the drugs or a standard treatment (fingolimod). The goal is to see which drug is safer and b…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Heart hole repair without X-Rays: major trial launches
Disease control Not yet recruitingThis large study tests whether closing a common heart hole (atrial septal defect) using only ultrasound guidance and special tools is as good as the standard X-ray method. The goal is to avoid radiation and contrast dye risks, such as cancer and kidney injury. About 666 participa…
Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New keytruda copycat tested for melanoma prevention
Disease control Not yet recruitingThis trial tests AVT32-DRL_PB, a biosimilar (copy) of the cancer drug Keytruda, in 120 people with stage IIB/C or III melanoma whose tumors were fully removed. Half get the biosimilar, half get Keytruda, every 3 weeks. The main goal is to see if drug levels in the blood are simil…
Phase: PHASE1 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
One-Patient trial aims to treat Ultra-Rare genetic disorder
Disease control Not yet recruitingThis study tests a custom-made drug called an antisense oligonucleotide (ASO) designed for one person with Schuurs-Hoeijmakers syndrome, a rare genetic condition. The drug aims to correct a specific genetic mutation to improve communication and motor skills. Only one participant …
Phase: PHASE1, PHASE2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a cheap arthritis pill prevent deadly clots after heart valve replacement?
Disease control Not yet recruitingThis study tests whether a daily low-dose anti-inflammatory drug (colchicine) can prevent blood clots from forming on replacement heart valves after a minimally invasive valve procedure (TAVR). About 116 people who have had TAVR will either receive colchicine plus standard care o…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could your own stem cells fight this rare brain disorder?
Disease control Not yet recruitingThis study tests whether a person's own stem cells, processed and given by IV, can safely help with multiple system atrophy (MSA) — a rare, worsening brain disease that affects movement and automatic body functions like blood pressure. Fifty adults aged 35 to 65 will receive eith…
Phase: PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could an allergy pill help heal the brain in MS? new trial aims to find out
Disease control Not yet recruitingThis study tests whether clemastine fumarate, an over-the-counter allergy medication, can repair damaged nerve insulation (myelin) in people with multiple sclerosis. About 44 adults with relapsing-remitting MS will receive either the drug or a placebo for 3 months, then all will …
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Growing heart valve could spare kids multiple surgeries
Disease control Not yet recruitingThis study tests a special heart valve that can be adjusted to fit children as they grow. It involves 36 kids aged 1.5 to 16 years with congenital heart disease who need a new pulmonary valve. The valve is placed during surgery and can later be expanded without another operation.
Phase: NA • Sponsor: Autus Valve Technologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug cocktail aims to shrink NF1 tumors
Disease control Not yet recruitingThis early-stage trial tests whether two cancer drugs, cabozantinib and selumetinib, can safely shrink plexiform neurofibromas in people aged 16 and older with neurofibromatosis type 1 (NF1). About 30 participants will receive the combination daily. The study first finds the safe…
Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for newborns: simpler syphilis treatment on trial
Disease control Not yet recruitingThis study tests whether a 10-day course of oral amoxicillin works as well as a single injected dose of penicillin to treat congenital syphilis in newborns up to 30 days old. About 374 infants across 12 U.S. sites will be randomly assigned to one of the two treatments. The goal i…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for advanced melanoma: immunotherapy combo tested in india
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs, nivolumab and relatlimab, in people with advanced melanoma that hasn't been treated before. The goal is to see if the combination is safe and helps shrink tumors. About 30 adults and teens (ages 12 and up) in India will t…
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New growth hormone injection aims to help short children grow taller
Disease control Not yet recruitingThis study tests a new drug called GenSci134, a growth hormone injection, in 128 children with idiopathic short stature (short height with no known cause). The trial has two parts: first, a single-dose phase to check safety and how the body processes the drug; second, a multiple-…
Phase: PHASE1, PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug combo aims to tame rare artery disease
Disease control Not yet recruitingThis study tests two new drugs, vunakizumab and ivarmacitinib, for people with active Takayasu arteritis (TAK), a rare disease that causes inflammation in large blood vessels. The trial will enroll 180 adults aged 18-70 whose disease is still active despite standard treatments. R…
Phase: PHASE4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could 4 months of antiviral drugs be enough for CMV-Infected newborns?
Disease control Not yet recruitingThis study compares a 4-month course of antiviral medication (ganciclovir or valganciclovir) against the standard 6-month course for babies born with moderate-to-severe congenital CMV infection. The goal is to see if the shorter treatment works just as well at preventing long-ter…
Phase: PHASE4 • Sponsor: Hu Bofei • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a simple antibiotic combo save lives after heart valve surgery?
Disease control Not yet recruitingThis study will test whether giving an extra antibiotic during a heart valve replacement procedure (TAVI) can lower the chance of bloodstream infection or death within 6 months. About 2,000 patients in Denmark will take part. Half will get the standard antibiotic, and half will g…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a simple steroid help tiny preemies escape breathing machines?
Disease control Not yet recruitingThis study tests whether giving the steroid betamethasone to extremely premature babies (born before 28 weeks) helps them come off breathing machines more easily and lowers their risk of chronic lung disease. About 100 babies will receive either standard NICU care plus betamethas…
Phase: PHASE2 • Sponsor: Khang Nguyen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New study tests better bone grafts for cleft palate patients
Disease control Not yet recruitingThis study compares two surgical techniques for repairing bilateral alveolar clefts (gaps in the upper jaw) using bone grafts from the hip. Twenty participants will receive either a solid bone block or loose bone chips. The goal is to see which method provides better bone volume …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for kids with tough cancers: drug combo trial launches
Disease control Not yet recruitingThis study tests a combination of chemotherapy drugs (liposomal irinotecan, vincristine, and temozolomide) with or without an additional drug (anlotinib) in children aged 3-18 whose solid tumors have returned or not responded to treatment. The goal is to see if this combination c…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New Real-World study tracks fabry Drug's Long-Term impact on heart and kidneys
Disease control Not yet recruitingThis study follows 75 adults with Fabry disease who are taking or starting pegunigalsidase alfa to see how well it works and how safe it is over time in real-world settings. Researchers will check heart structure and function, kidney health, and exercise capacity. The goal is to …
Sponsor: Chiesi Italia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Double balloon blast may boost TAVI valve fit
Disease control Not yet recruitingThis study tests whether adding a second balloon inflation (called 'double tap') after placing a new heart valve improves how well the valve opens and works. About 250 adults with severe aortic stenosis getting a TAVI procedure will be randomly assigned to receive the standard pr…
Phase: NA • Sponsor: The Alfred • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a simple supplement protect Kids' guts during heart surgery?
Disease control Not yet recruitingThis study tests whether a butyric acid supplement, taken daily for three weeks before heart surgery, can safely improve gut health and reduce inflammation in infants and young children (ages 1 month to 3 years) with congenital heart disease. Researchers will monitor side effects…
Phase: PHASE1, PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Engineered t cells take on Hard-to-Treat cancers in new trial
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with advanced ovarian cancer or other solid tumors that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells that are genetically modified to better recognize and attack cancer…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New balloon treatment aims to keep leg arteries open longer
Disease control Not yet recruitingThis study will test a special balloon coated with the drug paclitaxel to treat long blockages in the leg arteries. About 300 people with severe leg pain or wounds will receive the balloon treatment during a standard angioplasty procedure. Researchers will track how well the arte…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Immune cells injected into spine to fight brain cancer
Disease control Not yet recruitingThis early-phase trial tests whether immune cells (CD8+ T cells) given through a spinal tap are safe for people with melanoma that has spread to the lining of the brain. Only 8 participants will receive the treatment. The main goal is to check for side effects, not to cure the di…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New breathing method could ease preemie lung care
Disease control Not yet recruitingThis study tests whether a new breathing support called Pressure Targeted High Flow works as well as standard CPAP in premature infants with breathing problems. About 78 babies born before 33 weeks will try each method for 24 hours. Researchers will monitor breathing, oxygen need…
Phase: PHASE2 • Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Personalized cell therapy takes on advanced melanoma in new trial
Disease control Not yet recruitingThis Phase 2 trial tests whether a personalized cell therapy called HS-IT101 works better than chemotherapy for people with advanced melanoma that has stopped responding to standard treatments. HS-IT101 uses a patient's own immune cells, grown in large numbers in a lab, to fight …
Phase: PHASE2 • Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Which bone drug best prevents fractures after denosumab? new study aims to find out
Disease control Not yet recruitingThis study compares two bone-strengthening drugs, ibandronate and zoledronic acid, given after stopping denosumab in postmenopausal women with osteoporosis. The goal is to see which drug better maintains bone density and prevents fractures. About 52 women aged 50-85 who took deno…
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Heat therapy could shrink blood vessel clumps without major surgery
Disease control Not yet recruitingThis study tests a minimally invasive procedure called microwave ablation to treat abnormal blood vessel clusters (vascular malformations) that cause pain and swelling. 150 patients will receive one session of this heat-based treatment, guided by ultrasound. Researchers will trac…
Phase: NA • Sponsor: Chengdu University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New stimulation device hopes to restore limb function after brain and spinal injuries
Disease control Not yet recruitingThis study tests a new device called SSMD, which uses non-invasive stimulation to help people with movement problems after stroke, traumatic brain injury, spinal cord injury, or peripheral nerve damage. 120 adults aged 18-80 with moderate to severe arm impairment will receive eit…
Phase: NA • Sponsor: Motion Informatics LTD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug cocktail takes on rare nerve tumors
Disease control Not yet recruitingThis early-phase trial tests a combination of three drugs—selumetinib, ZEN-3694, and durvalumab—in people with advanced sarcomas, including malignant peripheral nerve sheath tumors (MPNST) linked to NF1. The study first checks safety and dosing, then looks at whether the treatmen…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Engineered immune cells take aim at multiple sclerosis and myasthenia gravis
Disease control Not yet recruitingThis early-phase trial will test a new treatment called QT-019C in up to 15 adults with relapsed or refractory neurological autoimmune diseases, including multiple sclerosis, neuromyelitis optica, and myasthenia gravis. The treatment uses donor-derived CAR T-cells that target two…
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Double implant hope for kids born without ears
Disease control Not yet recruitingThis study will test whether using two OSIA bone conduction implants (one on each side) helps children with severe ear malformations hear better in noisy places compared to using just one implant. Twelve children aged 7 to 17 who already use a bone conduction device will receive …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New penile curvature surgery could reduce complications in kids
Disease control Not yet recruitingThis study compares two surgical techniques to correct severe penile curvature in children with hypospadias. The standard method uses a flap from the scrotum, which can cause extra surgery time and complications. The new method uses tissue from the urethra itself, aiming for a si…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Simple daily enema could end bedwetting accidents for kids
Disease control Not yet recruitingThis early study tests whether a daily enema made of salt water and glycerin can help children with fecal incontinence stay clean. The trial will include 30 children aged 3 to 16 who have bowel accidents at least once a week due to conditions like corrected anorectal malformation…
Phase: EARLY_PHASE1 • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Robot helper for heart valve surgery? new device tested in 158 patients
Disease control Not yet recruitingThis study tests a new device called the TAVR Assist System, which helps doctors perform a heart valve replacement procedure (TAVR) for severe aortic stenosis. The trial will compare the assist system to the standard manual TAVR in 158 older adults. The goal is to see if the devi…
Phase: NA • Sponsor: Zhicheng Medical Technology (Jiaxing) Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a supplement boost prostate cancer treatment?
Disease control Not yet recruitingThis early-phase trial tests whether adding a dietary supplement called LC-K76 to standard hormone therapy is safe for men with metastatic hormone-sensitive prostate cancer. Forty men will receive the supplement plus hormone therapy for 24 weeks, then be followed for another 24 w…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug may help kids with kidney disease avoid relapses
Disease control Not yet recruitingThis study tests whether one or two doses of ripertamab can help children aged 16 and older who have frequent relapses or steroid-dependent nephrotic syndrome. The goal is to see which dose works better at preventing relapses and reducing the need for steroids. The trial will enr…
Phase: NA • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New app aims to ease stress for families of kids with heart disease
Disease control Not yet recruitingThis study tests a WeChat mini-program designed to help families care for children after congenital heart disease surgery. The program provides health education, peer support, and remote monitoring. Researchers will compare families using the app to those receiving standard phone…
Phase: NA • Sponsor: ruijie YangLan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a cancer pill ease rare, painful skin diseases?
Disease control Not yet recruitingThis early-phase trial tests whether low doses of erlotinib, a drug originally used for cancer, can improve symptoms of rare genetic skin conditions called keratinopathies. About 44 adults with confirmed diagnoses will take increasing doses over 24 weeks. The goal is to see if it…
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Ancient herb granule takes on MS in new clinical trial
Disease control Not yet recruitingThis trial tests whether a traditional Chinese medicine called Yishen Daluo Yin granule can help people with relapsing-remitting multiple sclerosis. About 152 participants will take either the granule or a placebo twice a day for 24 weeks. The main goal is to see if the treatment…
Phase: NA • Sponsor: Ying Gao • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Estrogen showdown: gel or pill for turner syndrome puberty?
Disease control Not yet recruitingThis trial tests two ways of giving estrogen to girls and young women with Turner syndrome to help them start puberty. Participants will be randomly assigned to use either an estrogen gel applied to the skin or an estrogen tablet taken by mouth for 19 months. The study will compa…
Phase: PHASE2 • Sponsor: Universiti Kebangsaan Malaysia Medical Centre • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tests Chin-Plate device against facemask for underbite correction
Disease control Not yet recruitingThis study compares two ways to correct an underbite (Class III malocclusion) in children whose jaws are still growing. One method uses a facemask attached to a tooth-borne expander, while the other uses a chin-plate anchored to the bone with small screws. Researchers will measur…
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New digital tool aims to cut fall risk for MS patients
Disease control Not yet recruitingThis study tests a digital program that gives people with multiple sclerosis personalized strategies to avoid falls. About 80 participants who have trouble walking and have fallen recently will take part. The program uses each person's fall history to create tailored advice, and …
Phase: NA • Sponsor: Region Örebro County • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New breathing support could save tiny lungs
Disease control Not yet recruitingThis study compares two types of high-frequency ventilators for premature babies born before 32 weeks who have breathing problems. The new mode, HFOV-VG, aims to deliver more stable breaths to reduce lung injury. Researchers will see if it lowers the chance of severe chronic lung…
Phase: NA • Sponsor: Xingwang Zhu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy aims to prevent lung damage in tiniest preemies
Disease control Not yet recruitingThis study tests whether giving a special lung medicine (surfactant mixed with budesonide) to extremely premature babies who are still on a breathing machine at 7-14 days old is safe and can help prevent a serious lung condition called bronchopulmonary dysplasia. About 24 babies …
Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Berry good news? blackcurrants tested for bone health in new trial
Disease control Not yet recruitingThis early-stage trial is testing whether taking blackcurrant extract capsules can slow bone loss in women who have gone through menopause. The study will measure changes in bone density and gut bacteria over 12 months in 159 women aged 45-70. The goal is to see if the berries wo…
Phase: PHASE1 • Sponsor: University of Connecticut • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug hopes to stop bone loss in rare aging disease
Disease control Not yet recruitingThis phase 2 trial tests a drug called Progerinin in up to 5 adults with Werner syndrome, a rare condition that causes premature aging and bone loss. Participants take the drug twice daily for about a year. The main goal is to check safety and tolerability, not yet to prove it wo…
Phase: PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New CAR t cell therapy targets tough childhood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests whether a new cell therapy called B7-H3 CAR T cells is safe and can help children and young adults whose solid tumors have returned or stopped responding to standard treatments. About 40 participants will receive their own immune cells that have been …
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug cocktail shows promise for rare head and neck cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (pucotenlimab, lenvatinib, and temozolomide) given before and after surgery for people with a rare type of melanoma in the head and neck area. The goal is to see if this approach can shrink tumors and improve outcomes. About 30 adults…
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New surgical trick for hip dysplasia: using the Body's own ligament
Disease control Not yet recruitingThis study tests a surgical procedure that uses the ligamentum teres, a natural ligament in the hip, to help stabilize the joint in children with developmental hip dysplasia (DDH). The surgery involves creating a tunnel in the bone and threading the ligament through it to improve…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a diabetes drug help heart defect patients lose weight?
Disease control Not yet recruitingThis study tests the drug tirzepatide (Munjaro) in 30 obese adults with congenital heart disease. Over 6 months, half get the drug and half get a placebo. Researchers will check if it improves exercise ability, heart function, and cholesterol. It is one of the first studies to lo…
Phase: PHASE4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo aims to shield diabetic bones from breaking
Disease control Not yet recruitingThis study tests whether adding denosumab to standard care can strengthen bones and prevent fractures in 358 adults with type 2 diabetes who are at high risk for breaks. Participants will receive the drug or a placebo, and researchers will measure changes in bone density and frac…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New scan could spot childhood cancer more clearly
Diagnosis Not yet recruitingThis study tests whether a new type of PET scan (18F-MFBG) can detect neuroblastoma tumors as accurately as the current standard scan (123I-MIBG). About 84 children and adults with newly diagnosed, high-risk neuroblastoma will receive both scans to compare results. If the new sca…
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Can an ultrasound replace a catheter for Kids' heart surgery planning?
Diagnosis Not yet recruitingThis study looks at 115 children aged 6 months to 5 years who have a hole in the heart (VSD) and need surgery. Doctors want to see if an ultrasound probe placed in the food pipe (TEE) can measure heart pressure as accurately as the standard method using a thin tube (catheter) ins…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
One scan to catch two silent threats: MRI may spot bone and muscle loss in kidney patients
Diagnosis Not yet recruitingThis study explores whether a single MRI fat-fraction (MRI-FF) scan can accurately diagnose osteoporosis and sarcopenia (muscle loss) in people with chronic kidney disease (CKD). Researchers will compare MRI-FF results with standard DXA scans in 868 participants—half with CKD and…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New Total-Body PET scanner could revolutionize vasculitis diagnosis
Diagnosis Not yet recruitingThis study will test a new type of PET/CT scanner, called Long-Axial Field-of-View (LAFOV), to see if it can provide clearer images of blood vessel inflammation in people with large vessel vasculitis (LVV). The scanner is more sensitive and can image the whole body faster, potent…
Phase: NA • Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New imaging agent could improve detection of rare cancers
Diagnosis Not yet recruitingThis study will compare a new radioactive tracer, 18F-AmBF3TATE, to the standard tracer 68Ga-DOTATATE for PET scans in people with neuroendocrine tumors. The goal is to see if the new tracer is as good or better at finding tumors. About 51 participants will receive both tracers a…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New heart MRI could slash scan time and hassle
Diagnosis Not yet recruitingThis study tests a new cardiac MRI method called Free-Running Framework (FRF) that lets patients breathe normally and skips the sticky ECG electrodes. It captures a 3D image of the whole heart in one go, potentially making scans faster and more comfortable. Researchers will compa…
Sponsor: Matthias Stuber • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Magnetic tracer could replace radioactive dye in melanoma surgery
Diagnosis Not yet recruitingThis phase 3 trial tests whether a magnetic tracer (Magtrace) works as well as the standard radioactive dye plus blue dye for finding sentinel lymph nodes in people with melanoma. About 254 adults having surgery for melanoma will receive both tracers and be randomly assigned to h…
Phase: PHASE3 • Sponsor: Vastra Gotaland Region • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
New needle technique could pinpoint painful nerves more accurately
Diagnosis Not yet recruitingThis study tests a new way to inject numbing medicine directly into a specific nerve root to find out which nerve is causing back and leg pain. The goal is to see if this method is safer and more accurate than current techniques. About 80 adults with sciatica who are scheduled fo…
Phase: NA • Sponsor: Xi'an Honghui Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
AI could help spot baby hip issues earlier
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) software can accurately analyze hip ultrasound images from infants screened for developmental dysplasia of the hip (DDH). About 150 babies will have their routine hip ultrasound read by both a doctor and the AI, and researc…
Phase: NA • Sponsor: Pentacomp Systemy Informatyczne S.A • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Can AI match specialists in spotting heart trouble in kids?
Diagnosis Not yet recruitingThis study will check if a fast, bedside heart ultrasound performed by emergency doctors or interpreted by artificial intelligence can accurately detect heart problems in children who already have heart disease. About 200 children aged 0-21 will be included. The results will be c…
Sponsor: Nicklaus Children's Hospital f/k/a Miami Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Chest X-Ray may speed up heart defect detection in newborns
Diagnosis Not yet recruitingThis study will check how accurate chest X-rays are at finding congenital heart disease in newborns. Researchers will study 60 babies in the NICU who show signs of heart problems. Each baby gets a chest X-ray within 24 hours and an echocardiogram within 72 hours. By comparing the…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New DNA test could end years of uncertainty for mitochondrial disease patients
Diagnosis Not yet recruitingThis pilot study aims to develop a new digital PCR technique to more accurately diagnose mitochondrial diseases. Researchers will test the method on blood, urine, saliva, and muscle fiber samples from 4 patients. If validated, the technique could be faster and cheaper than curren…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThis study tests whether a new MRI contrast agent, gadopiclenol, can detect brain metastases earlier than standard methods in 180 patients with advanced lung, breast, or skin cancer. Participants will receive screening brain MRIs to compare diagnosis timing and accuracy. The goal…
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could a simple scan replace biopsies for cancer immunotherapy?
Diagnosis Not yet recruitingThis study tests a new PET imaging agent, 68Ga-cPP-BCH, to detect PD-L1 protein levels in tumors of people with lung cancer, melanoma, or other solid tumors. The goal is to see if this scan can identify who might benefit from anti-PD-1/PD-L1 immunotherapy without needing a tissue…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New study aims to find best way to measure foot calluses in diabetes
Diagnosis Not yet recruitingThis study compares several non-invasive methods to measure foot calluses (plantar hyperkeratosis) in 50 people, half with diabetes and half without. The goal is to find the most reliable technique for assessing callus hardness and stiffness, which could help prevent foot ulcers …
Phase: NA • Sponsor: University of Seville • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Quick quiz could spot brittle bones without costly scans
Diagnosis Not yet recruitingThis study will check whether two easy-to-use questionnaires (OST and ORAI) can accurately predict osteoporosis in 1,500 postmenopausal Turkish women aged 50-75. Researchers will compare the questionnaire results with the gold-standard DEXA bone density scan. If the tools work we…
Sponsor: Kayseri City Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Light therapy may shield kids with cancer from chemo mouth sores
Prevention Not yet recruitingThis study tests whether light therapy (photobiomodulation) can prevent mouth sores in children receiving chemotherapy. Fifty children aged 0-30 will receive daily light treatments during hospital stays and at home. Researchers will check if the therapy is easy to use and accepta…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Massive hong kong study aims to stop osteoporosis before it starts
Prevention Not yet recruitingThis study tests whether a program of exercise, lifestyle changes, and a smart chatbot can prevent osteoporosis and sarcopenia in 8,336 adults aged 40-60. Participants are split into two groups: one gets active support with structured workouts and reminders, the other gets basic …
Phase: NA • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:39 UTC
-
Simple foam dressings may shield heart surgery patients from painful bedsores
Prevention Not yet recruitingThis study tests whether placing soft foam dressings on the skin before heart surgery can prevent pressure injuries (bedsores). About 80 adults having long heart surgeries will be enrolled. Researchers will check for new skin injuries after surgery and track how severe they are. …
Phase: NA • Sponsor: Shih,Wen-Chi • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Phone apps aim to shield melanoma survivors from harmful UV rays
Prevention Not yet recruitingThis study tests five different smartphone programs designed to help melanoma survivors reduce unprotected sun exposure. About 150 participants will wear a UV sensor and activity monitor, complete daily surveys, and use the programs for 8 weeks. The goal is to see which programs …
Phase: NA • Sponsor: Northwestern University • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Could circumcision replace antibiotics for preventing kidney infections in newborns with PUV?
Prevention Not yet recruitingThis study looks at newborn boys with posterior urethral valves (PUV), a rare birth defect that raises the risk of serious kidney infections. It compares circumcision alone versus circumcision plus daily antibiotics to see if the surgery alone is enough to prevent these infection…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Heart drugs tested to stop AFib after TAVR
Prevention Not yet recruitingThis trial tests whether two heart medications, metoprolol and amiodarone, can prevent new-onset atrial fibrillation (AFib) in people who develop minor rhythm issues after transcatheter aortic valve replacement (TAVR). About 198 participants will be randomly assigned to one of th…
Phase: NA • Sponsor: Shanghai East Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Texts and calls could save lives: new study aims to boost baby vaccinations
Prevention Not yet recruitingThis study tests whether sending text messages or voice call reminders with helpful behavior change tips can improve how many babies get their full set of vaccines on time. About 7,800 caregivers of newborns in Bangladesh will be split into three groups: one gets no reminders, on…
Phase: NA • Sponsor: Japan Institute for Health Secutiry • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Pinhole contact lens aims to sharpen sight for two eye conditions
Symptom relief Not yet recruitingThis early study tests a special contact lens that has a tiny pinhole built in. The idea is that the pinhole helps focus light better, improving vision for people with presbyopia (age-related blurry near vision) or keratoconus (a cone-shaped cornea). Sixteen adults will try the l…
Phase: NA • Sponsor: Azalea Vision • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New study tests which laser technique clears kidney stones faster
Symptom relief Not yet recruitingThis study compares two ways to break up kidney stones using a laser and a suction device. One method turns stones into dust, the other into small fragments. The goal is to see which leaves fewer stone pieces behind after one month. About 86 adults with small kidney stones will t…
Phase: NA • Sponsor: Bir Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a morning light session boost immunotherapy? small trial aims to find out
Symptom relief Not yet recruitingThis pilot study tests whether using bright light therapy for an hour each morning, delivered through an iPad app, is tolerable for people with advanced melanoma or non-small cell lung cancer who are about to start immunotherapy. The idea is that synchronizing the body's internal…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
AI-Powered diet advice could help cancer patients eat better during treatment
Symptom relief Not yet recruitingThis study tests whether an AI-based website that gives personalized diet tips and recipes can help cancer patients who experience taste changes during therapy. About 198 adults with certain cancers (like multiple myeloma, melanoma, or GI cancers) will either get the AI tool or a…
Phase: NA • Sponsor: Wuerzburg University Hospital • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could aspirin ease pain in kids with rare vein condition?
Symptom relief Not yet recruitingThis study tests whether adding aspirin to a standard anti-inflammatory gel can reduce pain from blood clots in children aged 6 to 17 with superficial venous malformations. The trial will compare aspirin plus gel against a placebo plus gel over 14 days. Only 34 children will take…
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New rehab combo aims to ease MS fatigue and boost brain function
Symptom relief Not yet recruitingThis study tests whether a 12-week program combining individual physiotherapy, group movement-awareness sessions, and group psychotherapy can improve physical function, reduce fatigue, and enhance quality of life in 45 adults with multiple sclerosis. Each participant serves as th…
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New online tool aims to ease cancer worry in young adults
Symptom relief Not yet recruitingThis pilot trial tests whether adding emotional support to a cancer information website helps young adults (ages 20-39) with thyroid, melanoma, or testicular cancer feel less worried and distressed. 142 participants will either get general cancer info or the same info plus person…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a smartphone app help melanoma patients avoid severe side effects from immunotherapy?
Symptom relief Not yet recruitingThis study tests whether having melanoma patients regularly report their symptoms through an electronic tool, combined with quick access to specialist care, can improve the management of side effects from immune checkpoint inhibitors. These drugs can cause immune-related side eff…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could electromagnetic pulses help MS patients stay steady?
Symptom relief Not yet recruitingThis study tests whether a device that delivers high-intensity focused electromagnetic pulses can strengthen core muscles and improve balance in people with multiple sclerosis. Sixty participants will either receive the electromagnetic therapy plus balance exercises, or balance e…
Phase: NA • Sponsor: Middle East University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Nurse-Led video calls aim to empower MS patients
Symptom relief Not yet recruitingThis study tests a six-month personalized telenursing program for 110 adults with multiple sclerosis. Participants receive monthly educational videos and nurse-led video calls to help them better understand their health and navigate the healthcare system. The goal is to improve h…
Phase: NA • Sponsor: G. d'Annunzio University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Fasting during immunotherapy: a new way to boost treatment?
Symptom relief Not yet recruitingThis study looks at whether intermittent fasting is safe and doable for people with advanced solid tumors who are starting immunotherapy. About 90 participants will be split into three groups: no fasting, eating only during an 8-hour window each day, or fasting every other day. R…
Phase: NA • Sponsor: West Virginia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Robots take on fragile pelvis fractures in the elderly
Symptom relief Not yet recruitingThis study compares two surgical methods for treating unstable pelvic fractures in people aged 60 and older with osteoporosis. Half of the 88 participants will receive robot-assisted minimally invasive screw placement, while the other half will have conventional open surgery. The…
Phase: NA • Sponsor: Junbo Liang • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Play therapy may calm young heart patients before surgery
Symptom relief Not yet recruitingThis study tests whether structured play activities, done with a parent, can reduce anxiety in children with congenital heart disease before their surgery. About 204 children aged 0-12 will be randomly assigned to either receive therapeutic play plus standard care, or standard ca…
Phase: NA • Sponsor: First Affiliated Hospital of Kunming Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could Low-Oxygen breathing supercharge gait therapy for MS?
Symptom relief Not yet recruitingThis study tests whether breathing low-oxygen air for short periods right before walking training helps people with multiple sclerosis walk better and farther. Thirty-five participants will receive either the low-oxygen breathing or a sham (placebo) version, followed by treadmill…
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New online program aims to lift depression in MS patients
Symptom relief Not yet recruitingThis study tests whether an internet-based program called My MS Toolkit can help reduce depression in people with multiple sclerosis. The toolkit teaches skills based on cognitive behavioral therapy to manage common MS symptoms like fatigue, pain, and low mood. Researchers will c…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Simple leg exercises may tighten loose knees in Ehlers-Danlos syndrome
Symptom relief Not yet recruitingThis study tests whether a 12-week program of hamstring strengthening exercises can reduce knee looseness and pain in people with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD). Twenty participants will attend two supervised exercise classes p…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can morning light boost melanoma treatment? new trial tests simple iPad therapy
Symptom relief Not yet recruitingThis early-phase trial tests whether a home-based morning light therapy program can help people with advanced melanoma who are receiving tumor-infiltrating lymphocyte (TIL) therapy. The light therapy is delivered through an iPad app and aims to improve the body's natural sleep-wa…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Heart procedure may offer lasting migraine relief, new study hopes to prove
Symptom relief Not yet recruitingThis study looks at people with migraines who also have a small hole in the heart (PFO). Participants first take a blood-thinning drug (prasugrel) to see if their migraines improve. Those who respond are randomly assigned to either continue the drug alone or have a procedure to c…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could brief low-oxygen sessions help MS? small safety trial launches
Symptom relief Not yet recruitingThis early-stage study tests whether short periods of breathing low-oxygen air (called acute intermittent hypoxia) are safe and tolerable for people with multiple sclerosis. Nine participants at different disease stages will be closely monitored for side effects like low oxygen l…
Phase: PHASE1, PHASE2 • Sponsor: University of Saskatchewan • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Virtual park ride could boost rehab motivation for brain conditions
Symptom relief Not yet recruitingThis study tests whether using a virtual reality (VR) system during cycling exercise makes rehabilitation more motivating for adults with conditions like stroke, Parkinson's, multiple sclerosis, or frailty. About 70 participants will try cycling with and without VR over 4 weeks. …
Phase: NA • Sponsor: Marta Mondellini • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Tailored exercise may ease walking troubles for hispanics with MS
Symptom relief Not yet recruitingThis study tests a 16-week exercise program designed specifically for Hispanic people with multiple sclerosis who have walking problems. About 66 participants will either join the exercise group or a waitlist. The goal is to see if the program improves walking ability and quality…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Massage-like therapy may straighten posture and even faces, small trial suggests
Symptom relief Not yet recruitingThis study tests whether myofascial release therapy, a type of hands-on treatment that loosens tight connective tissue, can improve body posture and facial symmetry in healthy adults. Sixty participants will be randomly assigned to receive the therapy twice a week for six weeks o…
Phase: NA • Sponsor: Ece ACAR • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Nerve block may ease pain and speed recovery for kids after hip surgery
Symptom relief Not yet recruitingThis study looks at whether adding a special nerve block (PENG block) to standard spinal anesthesia can lower inflammation and pain in children aged 3 to 8 having hip surgery. One hundred children will be randomly assigned to receive either spinal anesthesia alone or spinal anest…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Essential oils tested as a natural remedy for MS bladder issues
Symptom relief Not yet recruitingThis study tests whether a daily topical blend of lavender and rosemary essential oils can reduce urinary urgency, frequency, and leakage in adults with multiple sclerosis. Sixty participants will use either the essential oil blend or a placebo oil for six weeks. Researchers will…
Phase: NA • Sponsor: University of Oran 1 • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
HIIT workouts may boost mobility and brain function in MS patients
Symptom relief Not yet recruitingThis study will test whether high-intensity interval training (HIIT) on a stationary bike can improve walking, balance, and thinking in people with multiple sclerosis (MS). Forty adults with mild to moderate MS will be randomly assigned to either HIIT or moderate-intensity contin…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Video games could get kids with heart disease moving
Symptom relief Not yet recruitingThis study tests whether playing motion-sensing Nintendo Switch games can help children and teens with congenital heart disease become more physically active. Thirteen participants aged 8-18 will wear activity monitors and follow a 12-week exergame program with coaching and suppo…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Prenatal therapy eases anxiety for moms of Heart-Defect babies
Symptom relief Not yet recruitingThis study tests a virtual psychological support program called HeartGPS for mothers whose babies are diagnosed with congenital heart disease before birth. About 210 mothers and their infants will take part, with some receiving the program plus usual care and others only usual ca…
Phase: NA • Sponsor: Carelon Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New Ultrasound-Guided IV could spare newborns painful needle sticks
Symptom relief Not yet recruitingThis study compares two types of IV catheters in 104 newborns with congenital syphilis who need 10 days of antibiotics. One group gets a standard short catheter, the other a longer catheter placed using ultrasound by a specialized nurse. The goal is to see which lasts longer and …
Phase: NA • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Fitbit and app aim to catch immunotherapy side effects early
Symptom relief Not yet recruitingThis study tests whether a digital tool combining weekly symptom surveys and a Fitbit can help monitor patients during immunotherapy for advanced melanoma. Forty participants will be randomly assigned to use the tool or receive usual care. The goal is to see if the system is easy…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Soothing sounds may soothe tiny hearts after surgery
Symptom relief Not yet recruitingThis study tests whether playing soft music or using a musical mobile can reduce pain and stress in infants when chest tubes are removed after heart surgery. Fifty-four babies aged 2 to 12 months will be randomly assigned to hear music, see a musical mobile, or receive standard c…
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Digital coach helps kids heal after heart surgery
Symptom relief Not yet recruitingThis study tests a digital exercise program that adapts in real time to help children aged 6 to 12 recover after congenital heart disease surgery. Kids wear a monitor and get personalized exercise prompts and feedback. Researchers will compare their recovery to children receiving…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
AR training aims to boost brain and body in MS patients
Symptom relief Not yet recruitingThis study explores whether augmented reality (AR) exercises can help people with multiple sclerosis (MS) improve both their walking and thinking at the same time. Researchers will create AR scenarios that combine physical and mental tasks, then test them in 40 adults with MS. Th…
Phase: NA • Sponsor: University of Sharjah • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Shock therapy for potty troubles? new study aims to help kids with bowel leakage
Symptom relief Not yet recruitingThis study compares two treatments for fecal incontinence in children aged 6 to 10 who had surgery for anorectal malformation. One group gets electrical stimulation alone, the other gets electrical stimulation plus biofeedback. The goal is to see which approach better strengthens…
Phase: NA • Sponsor: Sinai University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Tape trick: simple sticky strip may boost hand healing after tendon repair
Symptom relief Not yet recruitingThis study tests whether adding Kinesio Taping (a special elastic tape) to standard hand therapy can improve movement and strength after extensor tendon repair. About 36 adults with a specific finger tendon injury will be randomly assigned to get either real tape or a fake tape, …
Phase: NA • Sponsor: Pamukkale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could magnetic pulses ease MS depression and fatigue?
Symptom relief Not yet recruitingThis pilot study tests whether repetitive transcranial magnetic stimulation (rTMS) is safe and helpful for depression and fatigue in adults with multiple sclerosis (MS). About 20 participants will receive daily rTMS sessions for 5 days, with assessments before, after, and at a 4-…
Phase: PHASE1 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Virtual Nurse-Led program aims to boost purpose in women with MS
Symptom relief Not yet recruitingThis study tests whether a six-week, nurse-led virtual group program can help adult women with Multiple Sclerosis (MS) find more meaning and purpose in life, and improve their quality of life. Participants attend weekly online group sessions focused on reflection and values explo…
Phase: NA • Sponsor: Texas Woman's University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can a new serum tighten skin for women on ozempic?
Symptom relief Not yet recruitingThis study tests a topical serum called AGE serum on 50 post-menopausal women (ages 45-65) who are taking GLP-1 drugs like Ozempic or Wegovy, with half also on hormone therapy. The goal is to see if the serum safely improves skin firmness, fine lines, and radiance. Researchers wi…
Phase: NA • Sponsor: Goldman, Butterwick, Fitzpatrick and Groff • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Brain zaps aim to ease MS symptoms
Symptom relief Not yet recruitingThis study tests if a gentle brain stimulation technique called tDCS can improve movement, balance, fatigue, sleep, and thinking in people with multiple sclerosis. Forty adults with MS will receive either real or sham stimulation over two weeks. Researchers will check if the trea…
Phase: NA • Sponsor: University of Sharjah • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can exercise help advanced MS? new study aims to find out
Symptom relief Not yet recruitingThis study will test whether a 12-week aerobic exercise program is practical and safe for 12 people with advanced multiple sclerosis who use wheelchairs. Participants will exercise twice a week under supervision. Researchers will measure fitness, daily function, thinking skills, …
Phase: NA • Sponsor: University of Ottawa • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Rocking, swaddling, and white noise: a new way to soothe babies after heart surgery?
Symptom relief Not yet recruitingThis study looks at whether a multifunctional baby carrier that rocks, swaddles, and plays white noise can help infants (0-3 months old) feel less pain, sleep better, and have steadier heart rates and oxygen levels after congenital heart surgery. About 52 babies will be randomly …
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Simple leg sleeves may boost heart function during exercise in fontan patients
Symptom relief Not yet recruitingThis study tests whether wearing compression garments on the legs can increase the amount of blood the heart pumps during exercise in adults with Fontan circulation. Twenty participants will undergo exercise tests with and without the garments, and a subset will wear them for two…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can acupuncture needles Kick-Start a paralyzed stomach after cancer surgery?
Symptom relief Not yet recruitingThis study tests whether electroacupuncture (mild electrical pulses through thin needles) can help patients whose stomachs stop working properly after surgery for digestive tract tumors. Seventy-six adults who had such surgery and developed gastroparesis (stomach paralysis) will …
Phase: NA • Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Hip pain study tests app to ease depression and anxiety in young adults
Symptom relief Not yet recruitingThis study looks at whether a smartphone app that teaches cognitive behavioral therapy can help young adults (ages 15-39) with hip pain feel less depressed, anxious, and stressed. Researchers will also measure pain, physical function, and opioid use. Half of the 150 participants …
Phase: NA • Sponsor: Michael C Willey • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Exercise may shield the brain in MS patients, new trial hopes to prove
Symptom relief Not yet recruitingThis study will test whether a 12-week progressive resistance training program can improve brain health and daily function in people with relapsing-remitting multiple sclerosis. Thirty participants will be randomly assigned to either an exercise group or a control group. Research…
Phase: NA • Sponsor: Firat University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Virtual reality at home could help MS patients regain hand control
Symptom relief Not yet recruitingThis study tests whether a home-based virtual reality (VR) headset program can improve manual dexterity in people with multiple sclerosis (MS). Sixty participants with MS who have trouble with hand function will be randomly assigned to either the VR dexterity training or a sham m…
Phase: NA • Sponsor: Christian Kamm • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Pilates from home: a new hope for MS symptoms?
Symptom relief Not yet recruitingThis study will test whether doing Pilates exercises at home via video calls for 16 weeks can help people with multiple sclerosis (MS) walk farther and faster, improve balance, reduce fatigue and pain, and boost mood and thinking. About 50 adults with mild to moderate MS who can …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New buttock tightening injection under study
Symptom relief Not yet recruitingThis study tests a treatment called Juläine™, which is injected into the buttocks to improve skin looseness. About 100 adults with mild to moderate skin sagging will take part. Some get treatment right away, others wait a few months. The main goal is to see if skin elasticity imp…
Phase: NA • Sponsor: Nordberg Medical AB • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Tylenol tested as a secret weapon against MS walking fatigue
Symptom relief Not yet recruitingThis study tests whether acetaminophen (Tylenol) can reduce walking fatigue in people with multiple sclerosis. Twenty participants will take either the drug or a placebo, then walk on a treadmill until they get tired. A week later, they repeat the test with the opposite pill. The…
Sponsor: Hunter College of City University of New York • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Mind over MS: brain training device aims to restore arm movement
Symptom relief Not yet recruitingThis study tests a wearable brain-computer interface (BCI) that gives real-time feedback during mental exercises to improve arm movement in people with multiple sclerosis. Forty participants will either receive BCI training plus standard rehab or standard rehab alone for 12 weeks…
Phase: NA • Sponsor: Pasquale Arpaia • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Zyrtec vs. benadryl: which allergy pill is better for MS patients before infusions?
Symptom relief Not yet recruitingThis study tests whether cetirizine (Zyrtec) causes less sleepiness than diphenhydramine (Benadryl) when used as a pre-medication before anti-CD20 infusions for multiple sclerosis. Sixty participants will receive either drug 30-60 minutes before their infusion, and researchers wi…
Phase: PHASE3 • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Diamond-Infused cream may speed healing after face laser
Symptom relief Not yet recruitingThis study tests whether a special nanodiamond cream (Pavise ECMR) helps the skin heal better after facial laser treatment for wrinkles and loose skin. Eight adults aged 35-70 will receive the cream on one side of their face and standard care on the other. Researchers will check …
Phase: PHASE2 • Sponsor: Goldman, Butterwick, Fitzpatrick and Groff • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a common supplement ease severe behaviors in rare genetic disorder?
Symptom relief Not yet recruitingThis pilot study tests whether N-acetylcysteine (NAC), an antioxidant supplement, can reduce repetitive and self-injurious behaviors in people with Cornelia de Lange syndrome (CdLS). Ten participants aged 13–35 will receive both NAC and a placebo in random order over 18 weeks. Th…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Sugar water shots may ease back pain in Bendy-Bodied patients
Symptom relief Not yet recruitingThis study tests if injecting a sugar-water solution into the lower back, guided by ultrasound, can safely reduce chronic pain in people with hypermobile Ehlers-Danlos syndrome (hEDS). About 40 adults with hEDS and low back pain will receive the injections and report their pain l…
Phase: PHASE3 • Sponsor: Tulane University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a simple fluid prevent dangerous drops in blood pressure during heart surgery?
Symptom relief Not yet recruitingThis study tests whether giving a special fluid (colloid) before anesthesia can prevent blood pressure drops in 116 people undergoing transcatheter aortic valve replacement (TAVR). Participants will receive either the colloid or a standard salt solution before anesthesia. The goa…
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can online speech therapy match in-person results for kids with cleft palate?
Symptom relief Not yet recruitingThis study aims to see if online speech therapy works as well as face-to-face sessions for children aged 5 to 11 with repaired cleft palate. Sixty-four children will receive 30-minute speech therapy twice a week for 10 weeks, either online or in person. Researchers will measure i…
Phase: NA • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Lycra shorts tested as a simple fix for hip pain
Symptom relief Not yet recruitingThis pilot study will test whether wearing dynamic lycra shorts during daily activities can reduce pain and improve stability in adults with hip dysplasia and hypermobility. The study will enroll 12 participants and focus on whether it's feasible to run a larger trial. Researcher…
Phase: NA • Sponsor: Royal National Orthopaedic Hospital NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Video game therapy could help MS patients regain arm strength
Symptom relief Not yet recruitingThis study tests whether a home-based video game exercise program can improve arm and hand function in people with multiple sclerosis (MS). Forty adults with MS will be randomly assigned to either the exergame program or standard home exercises, both supervised remotely. The goal…
Phase: NA • Sponsor: Marina Castel Sánchez • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New collagen injection aims to smooth wrinkles and plump skin
Symptom relief Not yet recruitingThis early trial tests an injectable collagen-based product called MEC REGENERATE® in 20 adults aged 35–65 with skin laxity, mid-face volume loss, or wrinkles. Participants receive a single injection session, and researchers check safety and skin hydration after 60 days. The goal…
Phase: NA • Sponsor: 303 Pharma s.r.l. • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Phone coaching aims to ease cancer symptoms for patients and caregivers
Symptom relief Not yet recruitingThis study tests whether adding telephone health coaching to a symptom management handbook helps reduce symptom burden and improve quality of life for people with metastatic breast, GI, or melanoma cancer and their caregivers. About 200 participants will be split into two groups:…
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New therapy aims to steady the steps of MS patients
Symptom relief Not yet recruitingThis study tests whether sensory integration therapy can improve walking stability and quality of life in people with multiple sclerosis (MS). About 44 adults with relapsing-remitting MS will be randomly assigned to receive either the therapy or standard care. The therapy uses sp…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Shoes that could change how stroke survivors walk
Symptom relief Not yet recruitingThis study looks at whether custom-made shoes can improve walking quality in people who have had a stroke and still have trouble walking due to muscle tightness and foot dragging. About 58 adults who had a stroke at least 6 months ago will wear adapted shoes and be tested on how …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Could clear priming reduce inflammation after infant heart surgery?
Symptom relief Not yet recruitingThis study looks at whether using clear, non-blood fluids to fill the heart-lung machine during surgery can reduce inflammation in infants having a hole in the heart repaired. Sixty babies aged 1 to 18 months will be enrolled. Researchers will measure inflammation markers and rec…
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
VR headset aims to zap MS fatigue in new trial
Symptom relief Not yet recruitingThis pilot study tests whether a special virtual reality headset that delivers rhythmic light and sound (gamma sensory stimulation) can reduce fatigue in people with multiple sclerosis. Thirty participants with moderate to severe fatigue will receive either the active stimulation…
Phase: NA • Sponsor: Clarity Health Technologies, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New study aims to improve pain control for kids after hip surgery
Symptom relief Not yet recruitingThis study compares two medicines, dexmedetomidine and ketamine, added to a standard painkiller (bupivacaine) given through a caudal block to control pain after hip surgery in children aged 1 to 6 years. The goal is to see which combination provides better pain relief, lasts long…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can diet boost immunotherapy? study tests High-Fiber and fasting in melanoma
Knowledge-focused Not yet recruitingThis study looks at whether adding a high-fiber diet and short-term fasting can help melanoma patients undergoing immunotherapy. Forty participants will follow a high-fiber diet, with half also doing 72-hour fasts during each treatment cycle, while 20 others serve as a control gr…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
Knowledge-focused Not yet recruitingThis study examines how a type of immune cell called gamma delta T cells adapt and function in critically ill patients, both with and without sepsis. Researchers will compare these cells in healthy people, non-septic ICU patients, and septic ICU patients. The goal is to understan…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could poor balance be the hidden link between MS fatigue and fear of falling?
Knowledge-focused Not yet recruitingThis study investigates whether balance problems explain why fatigue leads to a greater fear of falling in people with multiple sclerosis (MS). Researchers will assess fatigue, balance, and fear of falling in 40 adults with MS who can walk independently or with a device. The goal…
Sponsor: Uskudar University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Heart surgery aftermath: new study seeks to predict and prevent dangerous rhythm problems
Knowledge-focused Not yet recruitingThis study will look at data from 918 adults who had planned heart surgery to find out why some develop atrial fibrillation, a common and serious irregular heartbeat. The researchers will also examine whether newer anesthesia methods, like a nerve block, might help protect agains…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Deep dive into rare mouth cancer could unlock personalized treatments
Knowledge-focused Not yet recruitingThis study looks at a rare type of cancer called oral mucosal melanoma. Researchers want to improve how the cancer is staged by measuring how deep it goes into tissue and by studying its genetic makeup. They will follow 1,100 patients over time to see which treatments work best f…
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can your smartwatch replace a medical heart test? scientists put apple watch to the test
Knowledge-focused Not yet recruitingThis study checks whether an Apple Watch Series 9 can accurately measure key health indicators—like oxygen levels and exercise capacity—in adults with heart conditions such as congenital heart disease, heart failure, or coronary artery disease. Participants wear the smartwatch du…
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Dental scans and AI could spot rare bone diseases faster
Knowledge-focused Not yet recruitingThis study will take 3D scans of the inside of the mouth from 240 people with rare bone or cartilage diseases and from healthy volunteers. Researchers will use shape analysis and artificial intelligence to see if these scans can help tell different diseases apart. The goal is to …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
National study aims to slash lung infections in preterm babies
Knowledge-focused Not yet recruitingThis observational study will look at how often very low birth weight babies in Canadian NICUs get ventilator-associated pneumonia (VAP) and how these infections are treated. Researchers will compare different hospitals' approaches to diagnosis and care, with the goal of creating…
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Online training could sharpen Pathologists' eye for melanoma
Knowledge-focused Not yet recruitingThis study tests whether an online training platform called DermLoop Learn can improve how pathologists diagnose melanoma from skin lesion images. 258 pathologists will be randomly assigned to receive the training or not, and their diagnostic accuracy will be compared against a p…
Phase: NA • Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Long-Term study aims to unlock mystery of joint hypermobility and chronic illness
Knowledge-focused Not yet recruitingThis study will follow 100 health science students for at least 10 years to understand why some people with very flexible joints (hypermobility) develop chronic pain, fatigue, and other health issues while others do not. Researchers will measure balance, heart rate, and quality o…
Sponsor: Clarkson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could low vitamin c weaken bones? new study investigates
Knowledge-focused Not yet recruitingThis observational study will check vitamin C levels in 40 people with osteoporosis, comparing those who have had a spine fracture to those who haven't. The goal is to see if lower vitamin C is more common in the fracture group. No treatment is given; the study simply measures an…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to understand physical challenges in kids with nerve diseases
Knowledge-focused Not yet recruitingThis study will look at balance, core strength, leg strength, walking ability, and fatigue in 32 children aged 6-18 with demyelinating diseases (conditions affecting the protective coating of nerves). Each child will undergo a single session of non-invasive tests like balance exe…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple paper tool help melanoma patients make tough biopsy decisions?
Knowledge-focused Not yet recruitingThis study tests a paper-based decision aid designed to help people with intermediate-risk melanoma decide whether to have a sentinel lymph node biopsy. The tool provides clear information about the procedure, its risks and benefits, and helps patients think about their personal …
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple eye scan reveal hidden vision risks in preemies?
Knowledge-focused Not yet recruitingThis study uses a special eye scan (OCT angiography) to look at blood vessel development in the retinas of children born very prematurely (at or before 28 weeks) compared to those born full-term. The goal is to see if premature birth and related lung problems affect eye blood ves…
Phase: NA • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can we predict breathing problems in cleft surgery? new study aims to find out
Knowledge-focused Not yet recruitingThis study observes 150 infants and toddlers having cleft lip or palate repair to understand how often breathing complications occur and what factors increase risk. Researchers will use standard airway scoring tools to see if they can predict problems like laryngospasm or low oxy…
Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Infant skull study aims to unlock secrets of craniosynostosis
Knowledge-focused Not yet recruitingThis study looks at skull bone samples from 80 infants aged 3 to 12 months who have craniosynostosis, a condition where skull bones fuse too early. Researchers will measure the bone's strength, structure, and tissue makeup both near and far from the fused area. The goal is to bet…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breastfeeding moms needed for drug safety study
Knowledge-focused Not yet recruitingThis study will measure how much of the drug mirikizumab passes into breast milk in 14 breastfeeding women who take it for inflammatory bowel disease. Participants will provide milk samples over several weeks. The goal is to understand potential exposure to nursing infants, helpi…
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can exercise tame the immune system in MS? new study investigates
Knowledge-focused Not yet recruitingThis study looks at how different types of exercise—aerobic and resistance training—affect the immune system and physical abilities in people with relapsing-remitting multiple sclerosis (MS). Researchers will measure changes in blood markers of inflammation and functional tests l…
Phase: NA • Sponsor: Seda Saka • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can when you eat protect your brain from MS?
Knowledge-focused Not yet recruitingThis study looks at whether the time of day you eat can affect brain health in people with multiple sclerosis. Twenty-two adults with MS will follow a daily eating schedule for a set period. Researchers will measure markers of nerve health and inflammation in the blood. A small g…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New decision aid aims to ease tough choices for rare heart defect
Knowledge-focused Not yet recruitingThis study is creating a decision aid for people with a rare heart condition called right anomalous aortic origin of a coronary artery (R-AAOCA). The condition raises the risk of sudden cardiac death, but the best management—surgery or careful observation—isn't clear. The aid wil…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Massive MS study aims to unlock secrets of disability progression
Knowledge-focused Not yet recruitingThis study will follow 2,000 people with multiple sclerosis (MS) for five years to understand why some get worse faster than others. Researchers will use brain scans, eye exams, blood tests, and activity monitors to track changes. The goal is to find factors—like inflammation, bl…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can ECG algorithms pinpoint dangerous heart rhythms in tetralogy of fallot patients?
Knowledge-focused Not yet recruitingThis study checks whether three common ECG-based methods can accurately locate where abnormal heart rhythms start in adults who had Tetralogy of Fallot repair. Researchers will pace the heart from known spots during a scheduled procedure and compare the predicted location to the …
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Heart valve unit may cut brain fog after procedure, study hopes
Knowledge-focused Not yet recruitingThis study will follow 500 people with severe aortic stenosis who need a heart valve replacement. Researchers want to see if a dedicated Heart Valve Unit—a team of heart specialists working together—can reduce confusion, delirium, and memory problems that sometimes happen after t…
Sponsor: Heart and Brain Research Group, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Gene-Guided surgery may spare kids from unnecessary knife
Knowledge-focused Not yet recruitingThis study looks at whether using genetic markers from a child's skin tumor can help doctors decide how much surgery is needed. About 51 children and young adults up to age 25 with localized melanoma or similar growths will have their tumor tissue reviewed centrally. Based on ris…
Phase: NA • Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Scientists hunt for autism genes in large blood study
Knowledge-focused Not yet recruitingThis study aims to collect blood samples from 450 people, including individuals with autism spectrum disorder (ASD), their relatives, and healthy controls. Researchers will isolate cells from the blood to study genetic factors and biological processes linked to autism. The goal i…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Birthmark size may predict hidden defects in babies
Knowledge-focused Not yet recruitingThis study looks at babies with a common type of birthmark (infantile hemangioma) on the lower back, bottom, or genital area. The goal is to find the best size cutoff for the birthmark to decide which babies should be screened for LUMBAR syndrome, a condition that can involve hid…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heart valve showdown: which TAVI valve sends fewer particles to the brain?
Knowledge-focused Not yet recruitingThis study will compare two common types of heart valves used in TAVI (a procedure to replace a narrowed aortic valve) to see which one sends fewer tiny particles to the brain during the procedure. 80 adults with severe aortic stenosis will be randomly assigned to receive either …
Phase: NA • Sponsor: Ivan Zeljkovic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Could a tiny skin shot replace harsh full-body immunotherapy for melanoma?
Knowledge-focused Not yet recruitingThis early-phase study tests whether a low-dose immunotherapy injection directly into the tumor can activate the immune system as effectively as standard high-dose treatment through the veins, but with fewer side effects. About 18 adults with advanced melanoma will receive either…
Phase: PHASE1, PHASE2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Rare syndrome linked to higher post-transplant cancer risk – study aims to find out why
Knowledge-focused Not yet recruitingDenys-Drash syndrome is a rare genetic condition that causes kidney failure in early childhood, often requiring a transplant. Past research suggests these children have a much higher chance of developing a type of lymphoma after transplant compared to other kids. This study will …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
5,500 patients to test new heart valve devices in massive safety study
Knowledge-focused Not yet recruitingThis study will follow 5,500 people in China who receive new heart valve devices (replacement or repair) for conditions like aortic stenosis or mitral regurgitation. Researchers will track safety issues such as stroke, bleeding, and device function over time. The goal is to see h…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Massive new registry to track menopause health in 5,000 women
Knowledge-focused Not yet recruitingThis study is a registry that will collect health information from up to 5,000 women experiencing perimenopause, menopause, or premature ovarian insufficiency. Researchers will gather data from medical records and ongoing visits to a specialized clinic, tracking symptoms, treatme…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New heart camera aims to make procedures safer
Knowledge-focused Not yet recruitingThis study will test a new ultrasound catheter called VeriSight Pro that takes pictures from inside the heart. Doctors will use it during procedures like closing a hole in the heart or fixing a valve. The goal is to see if it helps guide these procedures safely and effectively. A…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Moringa powder tested to boost breast milk and baby health
Knowledge-focused Not yet recruitingThis study looks at whether taking moringa leaf powder daily can help breastfeeding mothers produce more milk and improve the health of both mom and baby. About 100 mothers and their newborns will be randomly assigned to eat porridge with or without moringa for four months. Resea…
Phase: NA • Sponsor: Philip Kern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Scientists probe cellular 'Power Plants' to unlock secrets of aging
Knowledge-focused Not yet recruitingThis study looks at how aging changes tiny parts of our cells called mitochondria, which produce energy. Researchers will take small skin samples and blood from 90 healthy adults aged 18-90 to measure inflammation and cell aging markers. The goal is to better understand why we ag…
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New drilling technique could make dental implants more stable in weak bone
Knowledge-focused Not yet recruitingThis study compares two ways to prepare the jawbone for dental implants in people with low bone density. One method uses Densah burs to compact bone, while the other removes bone with standard drilling. The goal is to see which gives better implant stability right after placement…
Phase: NA • Sponsor: Suez Canal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
No needles needed: new device may measure heart pressure through the arm
Knowledge-focused Not yet recruitingThis study tests a new method to measure central venous pressure (a key heart health indicator) without inserting a catheter. Researchers will use a pressure cuff and Doppler sensor on the forearm of 30 children (ages 0-17) in the intensive care unit. The goal is to see if this n…
Sponsor: Le Bonheur Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Can a new guideline help mothers breastfeed babies with heart defects?
Knowledge-focused Not yet recruitingThis study tests a special breastfeeding guideline for infants born with congenital heart disease (CHD). Researchers want to see if the guideline helps more mothers breastfeed directly and reduces stress. About 266 mother-infant pairs will take part across multiple hospitals, wit…
Phase: NA • Sponsor: Carelon Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New ultrasound score may better monitor rare artery disease
Knowledge-focused Not yet recruitingThis study will test whether a special ultrasound score, called OTUS, can accurately track disease activity in people with Takayasu arteritis, a rare condition that causes inflammation of the large arteries. Researchers will follow 100 patients with active disease, performing ult…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New nursing program aims to boost development in toddlers after heart surgery
Knowledge-focused Not yet recruitingThis study tests a nursing support program for families of children aged 1 to 3 who have had heart surgery. The program includes education and counseling sessions to help parents improve caregiving skills and support their child's growth. Researchers will compare families who rec…
Phase: NA • Sponsor: Cukurova University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
MS Patients' sense of smell under the microscope
Knowledge-focused Not yet recruitingThis study looks at how multiple sclerosis (MS) might change a person's sense of smell and the related nerve sensations in the nose. Researchers will test 200 women with MS using simple smell and tickle tests, along with questionnaires about mood and thinking. The goal is to bett…
Sponsor: University of Catania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Eye twitch may signal early MS, new study hopes to find out
Knowledge-focused Not yet recruitingThis study examines patients who have internuclear ophthalmoplegia, a condition that causes trouble moving the eyes sideways, to see how many later develop multiple sclerosis (MS). Researchers will review medical records of 200 patients to identify factors that predict MS convers…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a simple walk test spot motor trouble in kids with NF1?
Knowledge-focused Not yet recruitingThis study looks at how young children with neurofibromatosis type 1 (NF1) walk, to see if simple walking tests can help doctors spot and predict movement problems early. Researchers will measure walking speed and other skills in 56 children under 6 years old. The goal is to crea…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can mindfulness stick? new study explores barriers for MS pain patients
Knowledge-focused Not yet recruitingThis study will enroll 80 adults with multiple sclerosis and chronic pain to take part in an 8-week online Mindfulness-Based Cognitive Therapy (MBCT) program. Researchers want to understand what emotional, physical, and environmental factors make it easier or harder to practice m…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
What’s it like to live with untreated fabry disease? a new study aims to find out
Knowledge-focused Not yet recruitingThis study will interview 35 adults in Sweden who have Fabry disease but are not yet receiving treatment. The goal is to learn how they experience their quality of life, daily activities, and healthcare support. By listening to patients' own stories, researchers hope to identify …
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Baby heart monitor tested during surgery
Knowledge-focused Not yet recruitingThis study watches babies under 3 months old who are having surgery to fix a narrowed heart artery. Doctors will check if a special monitor that measures blood flow matches other standard checks. No extra treatments or changes to care are involved.
Sponsor: Konya City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Heart defect closure study seeks to reveal hidden remodeling
Knowledge-focused Not yet recruitingThis study looks at how the heart's upper and lower chambers change shape and function after closing a hole called patent ductus arteriosus (PDA) using a catheter-based procedure. It will include 40 people aged 12 and older who are already scheduled for the closure. The goal is t…
Sponsor: Emil Magdy Badry • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to unravel Parkinson's protein mysteries
Knowledge-focused Not yet recruitingThis study looks at how abnormal proteins, like alpha-synuclein and tau, build up and affect brain function in people with Parkinson's disease. Researchers will use brain scans, blood tests, and skin biopsies to track these changes. The goal is to find better ways to diagnose and…
Phase: NA • Sponsor: University of Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New lung technique may boost heart function in kids after surgery
Knowledge-focused Not yet recruitingThis study looks at whether a special breathing maneuver during heart surgery can improve heart and lung function in children with congenital heart disease. About 80 children will be randomly assigned to receive either the maneuver or standard care. The goal is to see if this app…
Phase: PHASE1, PHASE2 • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New study to reveal hidden pancreatic issues in alagille syndrome patients after transplant
Knowledge-focused Not yet recruitingThis study aims to find out how often exocrine pancreatic insufficiency (EPI) occurs in people with Alagille syndrome who have had a liver transplant. About 30 participants aged 7 to 50 will eat a high-fat diet and collect stool samples for lab testing. The results will help doct…
Sponsor: Digestive Care, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Can playing piano tunes help detect MS brain fog?
Knowledge-focused Not yet recruitingThis pilot study will test whether a musical tool called Ipsilon can screen for and possibly improve cognitive function in people with multiple sclerosis (MS). Thirty-two participants will either use the Ipsilon for 15 minutes daily for a week or start with no intervention, then …
Sponsor: Hunter College of City University of New York • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Breathing test may replace overnight sleep studies for CPAP settings
Knowledge-focused Not yet recruitingThis study looks at whether a quick, non-invasive breathing test called impulse oscillometry (IOS) can help doctors find the right pressure settings for sleep apnea machines. Currently, patients often need an overnight sleep study to determine the correct pressure. The study will…
Sponsor: Mustafa Kemal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Immunotherapy may change how your body processes other drugs
Knowledge-focused Not yet recruitingThis study will test whether immunotherapy drugs (immune checkpoint inhibitors) change how the liver processes other medications. About 80 adults with various cancers who are starting immunotherapy will take a low-dose cocktail of 7 common drugs. Researchers will measure drug lev…
Phase: EARLY_PHASE1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Mindful calligraphy may boost your Cells' power plants
Knowledge-focused Not yet recruitingThis pilot study will test whether a daily 30-minute Tao Calligraphy mindfulness practice can increase mitochondrial DNA content in blood cells over 12 months. Fifty healthy or ill adults (excluding those with genetic diseases, cancer, or serious mental disorders) will provide bl…
Phase: NA • Sponsor: Sha Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New registry explores backup routes for heart valve procedure
Knowledge-focused Not yet recruitingThis study observes 600 people with aortic stenosis who cannot have a standard TAVI procedure through the leg artery. Instead, doctors will use other access points, like the chest or neck, to replace the heart valve. The goal is to track safety and success rates of these alternat…
Sponsor: Medical University of Silesia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
MS mystery: do some relapses hide from MRI scans?
Knowledge-focused Not yet recruitingThis study looks at whether people with relapsing-remitting multiple sclerosis (RRMS) can have a relapse—new or worsening symptoms—without any visible inflammation on an MRI scan. Researchers will follow 136 adults who are having a suspected relapse, performing early brain and sp…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Lab study explores better carrier for bone-healing protein
Knowledge-focused Not yet recruitingThis study uses blood samples from 20 dental patients to see how well a bone-growth protein (rhBMP-2) sticks to a natural blood-derived scaffold (E-PRF) and releases over time. Researchers compare this to the standard sponge carrier and combinations. The goal is to find a better …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Researchers check safety of stent grafts used in aortic aneurysm surgery
Knowledge-focused Not yet recruitingThis study looks back at medical records of 105 people who had a minimally invasive surgery called BEVAR to treat complex aortic aneurysms. Researchers want to see if two types of stent grafts (TUVA BX and iCover) are safe and work well. No new treatments are given; the study jus…
Sponsor: JOTEC GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New study seeks clues to recovery in rare childhood brain condition
Knowledge-focused Not yet recruitingThis study aims to find what factors predict recovery in children with acute disseminated encephalomyelitis (ADEM), a rare brain condition. Researchers will follow 25 children aged 6 months to 18 years to see how many recover fully and how many have relapses. The study does not t…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can a simple blood test predict MS worsening?
Knowledge-focused Not yet recruitingThis study will check if three substances in the blood (GFAP, NfL, and VEGF) are linked to how quickly disability gets worse in people with progressive multiple sclerosis. Researchers will measure these markers and compare them to standard tests of disability and thinking. The go…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
AI models tested to predict lung disease in preterm infants
Knowledge-focused Not yet recruitingThis study looks at whether artificial intelligence (AI) tools like ChatGPT, Gemini, and Claude can predict bronchopulmonary dysplasia (a serious lung condition) in premature babies. Researchers will use medical records from the first three weeks of life for 108 infants born befo…
Sponsor: Konya City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Study links walking fatigue to higher fall risk in MS patients
Knowledge-focused Not yet recruitingThis observational study looks at how walking fatigability—getting tired while walking—changes the way people with multiple sclerosis walk and increases their risk of falling. Researchers will compare two groups of 62 participants: those who experience walking fatigue and those w…
Sponsor: Ibrahim Ahmad Elmongy • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study to track gut emergencies in newborns
Knowledge-focused Not yet recruitingThis study will watch and record information from 120 newborns with serious gut problems admitted to the NICU. Researchers will track what types of emergencies are most common, how long babies stay in the hospital, and how many need surgery. The goal is to better understand these…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study aims to predict heart risks in pregnancy with simple monitoring
Knowledge-focused Not yet recruitingThis observational study will enroll 1,000 pregnant women and their fetuses to establish normal ranges for heart sounds and ECGs. The goal is to develop early warning systems for serious heart events in mothers, progression of fetal heart defects, and autoimmune-related fetal hea…
Sponsor: Yihua He,MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Hospital-Made 3D splints could save time and money in jaw surgery
Knowledge-focused Not yet recruitingThis study will compare custom 3D printed splints made at the hospital with those made by outside companies for jaw surgery. The splints help surgeons align the teeth and jaws correctly during the operation. Researchers want to see if the in-house splints are faster to get, cheap…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New turkish questionnaire aims to better measure bladder symptoms in neurological patients
Knowledge-focused Not yet recruitingThis study is translating and testing a short questionnaire called the Neurogenic Bladder Symptom Score Short Form (NBSS-SF) into Turkish. It will involve 120 adults with spinal cord injury or multiple sclerosis who have bladder problems. The goal is to make sure the Turkish vers…
Sponsor: Gaziantep Islam Science and Technology University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
MS frailty study seeks clues in blood and balance
Knowledge-focused Not yet recruitingThis study will compare frailty, physical fitness, and levels of a hormone called irisin in 782 people with multiple sclerosis and healthy volunteers aged 18-65. Researchers will use tests like the Frailty Index, Berg Balance Scale, and 6-Minute Walk Test, along with blood sample…
Sponsor: Baskent University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Exercise may shield MS brains from damage, small trial hopes to show
Knowledge-focused Not yet recruitingThis study will test whether a 12-week progressive resistance training program can improve brain health in people with relapsing-remitting multiple sclerosis. Researchers will measure brain volume and a nerve damage marker in the blood. The trial involves 26 participants and aims…
Phase: NA • Sponsor: Firat University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Can blood proteins predict bone and muscle loss in older women?
Knowledge-focused Not yet recruitingThis study will measure two proteins (myostatin and irisin) in the blood of 60 postmenopausal women aged 50-65. Researchers will group participants by bone density (normal, low, or very low) and test their muscle strength. The goal is to see if these proteins are linked to bone a…
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Researchers to visit homes of MS patients to see how they handle their meds
Knowledge-focused Not yet recruitingThis study looks at how people with multiple sclerosis (MS) understand and use their medicines at home. Researchers will visit participants once to review all medications and supplements, ask about routines and challenges, and check for safety issues. No changes to treatment will…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
MRI reveals hidden speech success after late cleft palate repair
Knowledge-focused Not yet recruitingThis study will use MRI scans to see how well the palate and throat muscles work after a special surgery for cleft palate repair. The surgery uses a piece of cheek muscle to close the gap and aims to improve speech. Ten people who have not had early treatment will get the surgery…
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Heart surgery may help small kids grow: study to track 58 infants
Knowledge-focused Not yet recruitingThis study looks at whether children who had surgery to close a large hole in their heart (called a VSD) will catch up in growth. Researchers will measure weight, height, and BMI before and after the procedure in 58 children aged 1 month to 2 years. The goal is to see how long it…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
AI and glucose monitors may predict surgery risks for rare tumors
Knowledge-focused Not yet recruitingThis study will enroll 200 patients scheduled for surgery to remove rare adrenal tumors called pheochromocytomas or paragangliomas (PPGL). Before surgery, researchers will use a model to predict the risk of severe blood pressure swings during the operation. During surgery, a real…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Waiting game: how treatment delays raise fracture risk
Knowledge-focused Not yet recruitingThis study will review medical records of 8,000 adults with osteoporosis who have had a fragility fracture. Researchers want to measure how long it takes for patients to start medication that prevents future fractures. They also want to see if longer delays lead to more fractures…
Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Cheek flap may boost bone growth in cleft repair
Knowledge-focused Not yet recruitingThis study looks at whether using a flap from the cheek (FAMM flap) helps bone grow better when repairing a cleft in the gum area. Five people aged 9 to 20 who already had braces to widen the palate will be included. Researchers will use 3D X-rays to measure bone height, width, a…
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Heart wave tech may predict TAVR success
Knowledge-focused Not yet recruitingThis study looks at whether advanced heart pressure wave analysis can predict how well patients recover after a TAVR procedure for severe aortic stenosis. Researchers will measure pressure waves during the procedure and track quality of life and heart complications over one year …
Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New study tests if teaching women about bone health can prevent osteoporosis
Knowledge-focused Not yet recruitingThis study aims to see if a structured education program based on the Health Belief Model can improve osteoporosis awareness and health beliefs in women aged 45 and older who have at least one risk factor for the disease. About 74 women will be randomly assigned to either receive…
Phase: NA • Sponsor: Bartın Unıversity • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Scientists investigate hidden genetic patterns in rare childhood disorders
Knowledge-focused Not yet recruitingThis study aims to better understand a condition called multilocus imprinting disorder (MLID), where multiple genes are affected by abnormal chemical marks. Researchers will test a new technique to detect these marks in 96 people, including those with known imprinting disorders a…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Electric foot lift: can a simple device improve walking after brain injury?
Knowledge-focused Not yet recruitingThis study looks at how a device called the L300, which uses mild electrical pulses to lift the foot during walking, affects people with stroke, traumatic brain injury, or multiple sclerosis. Researchers will measure walking speed, step length, and balance in 90 adults to see if …
Phase: NA • Sponsor: Casa Colina Hospital and Centers for Healthcare • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Rare syndrome study aims to map dental and facial patterns
Knowledge-focused Not yet recruitingThis study looks at the teeth, mouth, and face health of 25 people with Mowat-Wilson syndrome, a rare genetic condition. Researchers will check for cavities, gum disease, and facial features, and ask about quality of life. No treatment is given—the goal is to gather information t…
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Tiny viruses, big impact? study links early gut & lung viruses to preterm lung disease
Knowledge-focused Not yet recruitingThis study looks at 40 premature babies (born before 30 weeks) to see if viruses in their lungs and gut during the first three weeks of life are linked to a serious lung condition called bronchopulmonary dysplasia (BPD). Researchers will collect throat and stool samples to track …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Heart imaging revolution? 1000-Person study tests new MRI tech
Knowledge-focused Not yet recruitingThis study will test new MRI methods to find early signs of heart disease in 1000 adults. Researchers want to see if these scans can detect tiny changes in heart muscle before standard tests do. Participants will have MRI scans and blood work, but no treatment is given. The goal …
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Fabry disease diagnosis differs between men and women, new study aims to find out how
Knowledge-focused Not yet recruitingThis study will survey 200 adults with Fabry disease to understand how men and women experience different paths to diagnosis. Researchers want to see if symptoms or family screening lead to diagnosis more often in one sex, and how long diagnosis takes. The goal is to identify pat…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
MOGAD mystery: do headaches signal more?
Knowledge-focused Not yet recruitingThis study aims to find out how often headaches happen in people with MOGAD, a rare disease that affects the brain and nerves. Researchers will look at the medical records of 25 adults and also follow them forward in time to describe headache patterns. The goal is to better under…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
AI listens to your voice to predict heart patient frailty
Knowledge-focused Not yet recruitingThis three-year study in 410 adults with congenital heart disease aims to see if AI-powered voice emotion detection can predict frailty and improve mental health. Participants will complete surveys and interviews, and some will receive AI-guided counselling. The goal is to better…
Phase: NA • Sponsor: Mackay Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Blood clues to brain harm in child heart surgery
Knowledge-focused Not yet recruitingThis study looks at whether certain proteins in the blood can signal brain injury in children who have heart surgery with a heart-lung machine. Researchers will measure these proteins before and after surgery and compare them to the child's brain function. The goal is to find a s…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study aims to unravel mysterious Lung-Liver connection
Knowledge-focused Not yet recruitingThis study will follow 300 adults who have both a portosystemic shunt (an abnormal blood vessel connection between the liver and the rest of the body) and pulmonary hypertension (high blood pressure in the lungs). Researchers want to learn more about how common this combination i…
Sponsor: Chinese Pulmonary Vascular Disease Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study to measure daily life impact of rare bleeding disorder in youth
Knowledge-focused Not yet recruitingThis study looks at how hereditary hemorrhagic telangiectasia (HHT) affects the quality of life of children and young adults aged 2 to 25. Participants will fill out questionnaires about their physical, emotional, and social well-being. Researchers will also review medical record…
Sponsor: Ashley Nelson • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Brain-Training game could rewire MS Patients' minds
Knowledge-focused Not yet recruitingThis study tests whether a 'serious game'—a video game designed to train thinking skills—can change how the brain works in people with multiple sclerosis who have memory or attention problems. Forty participants will play the game and have brain scans before and after to see if b…
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Ultrasound maps hidden nerves in clubfoot babies to make surgery safer
Knowledge-focused Not yet recruitingThis study will use ultrasound to measure the distance between the Achilles tendon and nearby nerves and blood vessels in both feet of 40 infants with unilateral clubfoot. By comparing the clubfoot to the normal foot, researchers hope to give surgeons better guidance to avoid acc…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Dental implant dilemma: to keep or remove when jaw bone dies?
Knowledge-focused Not yet recruitingThis study looks at patients who develop a condition called MRONJ (bone death in the jaw) after taking osteoporosis medications. When this happens around a dental implant, doctors disagree on whether to remove the implant or try to save it. The study will compare healing and bone…
Phase: NA • Sponsor: Kyunghee University Dental Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Robot doctor calls: AI assistant to handle bone fracture Check-Ins
Knowledge-focused Not yet recruitingThis study is testing an AI voice assistant named Dora that makes automated phone calls to patients who have had a bone fracture. The goal is to see if Dora can safely and accurately collect information about risk factors and medication side effects, compared to a regular call fr…
Phase: NA • Sponsor: Ufonia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Which surgery is best for hirschsprung disease? new study aims to find out
Knowledge-focused Not yet recruitingHirschsprung disease is a rare birth defect where nerve cells are missing in part of the colon, causing severe constipation. Surgery to remove the affected section is the main treatment. This study compares two ways to do that surgery: one through the anus only, and another using…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can a heart monitor let TAVI patients go home sooner?
Knowledge-focused Not yet recruitingThis study looks at whether people with heart rhythm problems after a TAVI procedure can safely leave the hospital early if they wear a non-invasive heart monitor at home. About 100 adults who had a successful TAVI for severe aortic stenosis and have certain conduction disorders …
Phase: NA • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
MPS patients help design exercise program to boost mental health
Knowledge-focused Not yet recruitingThis study aims to create a physical activity and sedentary behaviour program tailored for adults with mucopolysaccharidosis (MPS). Researchers will gather input from patients, doctors, nurses, and family members through interviews, focus groups, and workshops. The goal is to des…
Sponsor: Brunel University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Brain training + exercise may help veterans with MS avoid falls
Knowledge-focused Not yet recruitingThis study looks at whether adding computer-based cognitive training to walking and resistance exercises can improve walking and reduce falls in older veterans with multiple sclerosis. Thirty veterans will take part in a 10-week program, and their falls will be tracked for a year…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Fiber fuel: could your diet boost melanoma treatment?
Knowledge-focused Not yet recruitingThis study looks at whether eating more fiber helps melanoma patients respond better to immunotherapy. Researchers will track the fiber intake of 60 patients using a special questionnaire and see if those who eat more fiber have less cancer recurrence or progression. The goal is …
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
600 cancer patients to help unlock secrets of immunotherapy success
Knowledge-focused Not yet recruitingThis study will follow 600 people with early-stage solid cancers (like lung, head and neck, melanoma, or bladder cancer) who are receiving immunotherapy before surgery. Researchers will collect blood and tumor samples at several time points to see how the immune system responds. …
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New program aims to guide young cancer survivors through Follow-Up care
Knowledge-focused Not yet recruitingThis study is for young adults (ages 21-45) who had certain cancers as teens or young adults. Researchers are adapting a program that helps survivors manage their health after cancer treatment. The goal is to see if this program improves survivors' confidence and ability to handl…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Could lead exposure worsen multiple sclerosis? new study investigates
Knowledge-focused Not yet recruitingThis study will examine whether lead exposure is linked to multiple sclerosis (MS). Researchers will measure blood lead levels, oxidative stress markers, and epigenetic changes in 140 people with MS and healthy controls. The goal is to better understand how environmental factors …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Leg strength may be key to heart health in rare condition
Knowledge-focused Not yet recruitingThis study looks at how leg muscle size and strength affect circulation in people born with a single-chamber heart, a condition where the heart can't pump blood to the lungs on its own. Researchers will measure muscle mass, oxygen use, and quality of life in 40 adults aged 16-50 …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Could your gums reveal clues about multiple sclerosis?
Knowledge-focused Not yet recruitingThis study will check the gum health of 100 people—half with multiple sclerosis (MS) and half without—by measuring gum pockets, plaque, and inflammation. Researchers will also test saliva for certain bacteria and viruses to see if they are linked to MS. The goal is to better unde…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Chewing problems in MS may signal brain health risks
Knowledge-focused Not yet recruitingThis study looks at whether chewing function is linked to cognitive skills, disease severity, and nutrition in people with multiple sclerosis. Researchers will assess 86 adults with MS using tests for disability, thinking, swallowing, chewing, and nutrition. The goal is to unders…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
PCOS study hunts for genetic clues behind severe insulin resistance
Knowledge-focused Not yet recruitingThis study aims to find out whether some women diagnosed with polycystic ovary syndrome (PCOS) actually have a rare genetic condition causing severe insulin resistance. Researchers will compare 25 women with a known LMNA gene mutation (linked to lipodystrophy) to 50 women with cl…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study to measure hidden toll of postpartum belly condition on Women's quality of life
Knowledge-focused Not yet recruitingThis study follows 30 women with postpartum abdominal wall insufficiency syndrome (PPAWIS) to understand how the condition affects their quality of life, body image, and sexual function. Participants will fill out surveys at the start and during follow-up while receiving their us…
Sponsor: Swissmed Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Rare hand deformity study seeks answers from medical records
Knowledge-focused Not yet recruitingThis study looks at medical records and parent questionnaires from about 28 children with a rare hand condition called longitudinal ulnar deficiency. The goal is to better understand how the condition changes over time and what factors lead to surgery. No new treatments or tests …
Sponsor: Hopitaux de Saint-Maurice • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Tiny noses, big clues: study hopes nose bugs predict preterm lung disease
Knowledge-focused Not yet recruitingThis study follows 270 preterm babies (born before 32 weeks) from birth to age 3. Researchers will regularly swab their noses to analyze the bacteria and other microbes living there. The goal is to see if the nose microbiome can predict which babies will develop bronchopulmonary …
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can hospitals boost vaccine access for the most vulnerable?
Knowledge-focused Not yet recruitingThis study will test a new way to offer vaccines to vulnerable patients—those with chronic diseases or weakened immune systems—during hospital visits. Researchers will see if offering, prescribing, and giving vaccines in the hospital increases how many people get vaccinated. The …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
MS treatment failure: the hidden emotional toll on patients
Knowledge-focused Not yet recruitingThis study looks at how treatment failure impacts the quality of life, anxiety, depression, and daily activities of 150 adults with relapsing-remitting multiple sclerosis. Researchers will use questionnaires to measure patients' well-being and their experience with care. The goal…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Breathing tests could reveal hidden disability in MS patients
Knowledge-focused Not yet recruitingThis study looks at whether simple breathing tests can help detect disability levels in people with multiple sclerosis (MS). Researchers will measure respiratory muscle strength and endurance in 40 adults with MS and compare the results to their disability scores. The goal is to …
Sponsor: Selcuk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New study aims to personalize care for tiny hearts
Knowledge-focused Not yet recruitingThis study focuses on extremely preterm infants (born before 32 weeks) who have a heart condition called hsPDA. Researchers will collect blood samples and health data to create a model that predicts which infants need treatment. They are also developing a targeted drug-delivery s…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Heart defects may stunt growth in infants, new study to investigate
Knowledge-focused Not yet recruitingThis study will review medical records of 72 children aged 1 month to 2 years with congenital heart disease (CHD) to see how their growth compares to healthy children. Researchers will measure weight, height, and head circumference. The goal is to understand which types of CHD af…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
MS study probes link between core strength and daily function
Knowledge-focused Not yet recruitingThis observational study will look at how trunk (core) stability is related to balance, walking ability, arm function, and fatigue in 64 people with mild to moderate multiple sclerosis. Participants will complete a series of standard physical tests in one session, such as timed w…
Sponsor: Cappadocia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Blood test may predict immunotherapy success in cancer patients
Knowledge-focused Not yet recruitingThis study looks at whether tiny particles in the blood, called extracellular vesicles, can help doctors predict if immunotherapy will work for people with advanced lung cancer or melanoma. Researchers will collect blood samples from 378 patients before and during standard treatm…
Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New ultrasound technique could spot heart issues in newborns earlier
Knowledge-focused Not yet recruitingThis study tests a more sensitive ultrasound method called speckle tracking echocardiography (STE) to check heart function in newborns. Researchers will scan healthy babies and those with conditions like lung disease or oxygen deprivation to establish normal values and track chan…
Sponsor: Birmingham Women's NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Tiny study aims to find best way to check blood thinner levels in kids
Knowledge-focused Not yet recruitingThis study looks at 22 children with congenital heart disease who are getting a blood thinner called heparin. Doctors want to see if taking blood from a central line (a special IV) gives the same results as taking blood from an artery. They will compare three different ways of dr…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
MS study: does multitasking mess with chewing?
Knowledge-focused Not yet recruitingThis study looks at how doing other things at the same time—like listening, watching, or moving—affects chewing in people with multiple sclerosis. Researchers will compare 48 adults with MS to healthy volunteers. The goal is to understand chewing problems better, not to test a tr…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
New device may help surgeons see blood flow during Kids' heart surgery
Knowledge-focused Not yet recruitingThis study will test a handheld device called IntraOx that uses light to measure oxygen levels in heart and liver tissue during complex heart surgery in children. The goal is to see if it can give surgeons useful information about blood flow without interfering with the operation…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Virtual reality goggles could revolutionize MS mobility tests
Knowledge-focused Not yet recruitingThis study will test whether mixed reality (using Meta Quest 3 goggles) can reliably measure walking, standing, and balance in 75 people with multiple sclerosis. Participants will perform standard mobility tests both conventionally and in a mixed reality environment. The goal is …
Sponsor: Selcuk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Rare pain condition under the microscope: no treatment, just answers
Knowledge-focused Not yet recruitingThis study aims to better understand pain in people with a rare genetic form of arthrogryposis (stiff joints) caused by a PIEZO2 mutation. About 12 participants aged 10 and older will track their pain daily for two weeks using simple questionnaires and body charts. No drugs or tr…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Heart valve study seeks hidden clues in rare amyloidosis link
Knowledge-focused Not yet recruitingThis study will observe 143 older adults with severe aortic stenosis who are scheduled for a minimally invasive valve replacement procedure called TAVR. Researchers want to find out how many also have cardiac amyloidosis, a condition where abnormal proteins build up in the heart.…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Scientists hunt for genes behind rare lung complication in liver bypass patients
Knowledge-focused Not yet recruitingThis study aims to find genetic variants that may explain why some people with a rare liver bypass condition (congenital portosystemic shunt) develop a serious lung complication called portopulmonary hypertension. Researchers will analyze blood samples from 120 patients and their…
Sponsor: Prof. Valérie Mc Lin • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Massive Real-World study to track brain and nerve autoimmune disorders
Knowledge-focused Not yet recruitingThis study will follow 1,550 adults with various neurological autoimmune diseases—like multiple sclerosis, myasthenia gravis, and autoimmune encephalitis—to see how these conditions progress and respond to treatments in everyday medical practice. Researchers will measure disabili…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Could a PET scan spot heart trouble in fabry disease before It's too late?
Knowledge-focused Not yet recruitingThis study will test a special PET scan tracer and blood tests to better understand and predict heart damage in people with Fabry disease. Researchers will look at heart tissue samples and blood markers from 20 adult patients. The goal is to find new ways to diagnose and forecast…
Sponsor: Núcleo de Apoio à Investigação Clínica - FMUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC